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ABSTRACT
Two New, Single-Isomer, Sulfated β Cyclodextrins for Use as Chiral Resolving Agents
for Enantiomer Separations in Capillary Electrophoresis. (May 2005)
Michael Brent Busby, B.S., University of Texas at Tyler; M.S., Texas A&M University
Chair of Advisory Committee: Dr. Gyula Vigh
Two novel, single-isomer, sulfated cyclodextrins, the sodium salts of heptakis(2-
O-methyl-3-O-acetyl-6-O-sulfo)cyclomaltoheptaose (HMAS) and heptakis(2-O-methyl-
6-O-sulfo)cyclomaltoheptaose (HMS) were used as chiral resolving agents in both
aqueous and non-aqueous electrophoretic separation of a set of pharmaceutically active
weak base enantiomers. Enantiomers of twenty one of the twenty four weak bases were
baseline resolved in one or more of the background electrolytes (BGEs) used.
An eight-step synthetic method was used to produce, on a large scale, the title
compounds in greater than 97% purity. The purity of the synthetic intermediates and the
final products were characterized by HPLC-ELSD and indirect UV-detection capillary
electrophoresis (CE), respectively. X-ray crystallography, MALDI-TOF mass
spectrometry and 1H as well as 13C NMR spectroscopy allowed for unambiguous
characterization of the structure of each intermediate and the final product.
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CHAPTER I
INTRODUCTION
1.1 Cyclodextrins as Chiral Resolving Agents
Cyclodextrin-based enantiomer separations are of continued interest to the
separation science community. Cyclodextrin-based enantiomer separations can be
accomplished by gas chromatography [1], liquid chromatography, including normal [2]
and reversed phase [3] and ion-chromatography [4], as well as electrophoretic techniques
including, capillary electrophoresis (CE) [5] , capillary isotachophoresis [6], free-flow
electrophoresis [7], and isoelectric focusing [8,9]. Compared to other enantiomer
separation technologies, CE is of the greatest importance to the pharmaceutical industry
where a large percentage of target molecules are chargeable, basic or acidic compounds.
For analytical application, CE is lowest in materials consumption and is less susceptible
to the various band broadening mechanisms that are inherent to gas chromatography
(GC) and high performance liquid chromatography (HPLC) [10]. CE does not require the
presence of a stationary phase to accomplish separation, unlike GC and HPLC, and only
a background electrolyte (BGE) containing dissolved buffer components and a chiral
selector, need to be prepared.
Cyclodextrins (CDs) serve as chiral complexing agents in CE where the
differences in the charge-to-mass ratio of the diastereomeric complexes can be
2distinguished. Cyclodextrins used for CE enantiomer separations include the native
species as well as those modified with various ionizable and non-ionizable functional
groups. Neutral cyclodextrins include native α-, β- and γ-CDs and those functionalized
with either methyl, acetyl or hydroxypropyl groups. Derivatives of β-CD are commonly
used for CE because of lower cost, greater commercial availability and higher aqueous
solubility compared to α-CD, γ-CD or their derivatives. Also, native CDs exhibit lower
aqueous solubilities than their functionalized derivatives: the solubility of β-CD is only
16-mM [11,12].  For these reasons, 2,6-dimethyl-β-CD, 2,3,6-trimethyl-β-CD and
hydroxypropyl-β-CD are among the most popular neutral cyclodextrin-based chiral
resolving agents.
Neutral CDs are not applicable for the analysis of neutral enantiomers. Charged
cyclodextrins are cyclodextrins modified to have either weakly or strongly acidic or basic
functionalies. Charged CDs extend the applicability of CE to uncharged enantiomers.
Typical examples of the weakly acidic and weakly basic functionalized CDs are
carboxylic acid and trialkylamine derivatives, respectively. The charge state of the
weakly acidic and basic CDs is pH dependent as is separation selectivity. The result is
more difficult method development than what is available with strongly acidic and basic
CDs [13]. The strongly acidic and strongly basic CDs are permanently charged over the
entire working pH range (pH 2-12) of CE and include sulfated CDs and those with
quaternary ammmonium functionalities, respectively. Use of the permanently charged
CDs allows for development of more robust separations where the conditions do not
have to be modified to suit the charge-state of the chiral resolving agent [14].
3Sulfated CDs are often more desirable for use in CE than those with quaternary
ammonium functional groups. Positively charged CDs have been shown to produce a
low efficiency mix of CE and open tube liquid chromatography due to adsorption of the
CD to the capillary wall. A model proposed by OKeefe et al. [15] considers that the CD
is tightly bound to the fused silica capillary wall yielding an overall fixed positive charge
at the capillary surface. The result is increased band broadening due to chromatographic
retention of the analytes and reversal of the electroosmotic flow (EOF) to a positive
value. Polyacrylamide coatings have been employed to reduce the effects of
chromatographic band broadening due to wall adsorption of the positively charged chiral
additive [16]. Anionic CDs do not exhibit the same wall coating tendency characteristic
of basic CDs so that capillary coatings are not required to prevent decreases in separation
efficiency [17].
All CDs thus far mentioned are commercially available as random mixtures of
isomers, characterized by their average degree of substitution. The composition of the
randomly substituted material varies from batch to batch, in both the population of the
various charged species and their relative proportions. Use of these cyclodextrins
introduces a significant degree of uncertainty into any analysis, since the mobility [18,
19], resolution [20] and indeed, the order of migration [21-25] of the enantiomers is
dependent on the molecular interaction of the enantiomers and the cyclodextrin additive.
Inhomogeneous materials received from the manufacturer result in run-to-run variations.
The only solution to this problem is the use of a consistently well characterized material.
The best solution to this is the use of single-isomer, sulfated cyclodextrins (SISCDs).
41.2 Synthesis of Single-Isomer, Sulfated Cyclodextrins
Four different synthetic strategies for producing fully functionalized single-
isomer cyclodextrins have been reported in the literature: i) one-step exhaustive per-
functionalization; ii) four step bi-functionalization of all hydroxy groups at the C2 and
C3 positions with identical functionality but different from that of the C6 position; iii)
five step bi-functionalization of all hydroxy groups at the C3 and C6 with identical
functionality but different from that of the C2 position; iv) five step functionalization at
the C2, C3 and C6 positions with all different groups. Attempts to produce a single-
isomer per-sulfated cyclodextrin using a one-step synthesis have thus far proven
unsucccessful [26]. Development of conditions using silyl-ether protecting groups for
selective modification [27-32] of CDs first heralded access to strategies ii) and iii) and
since has been successfully used to produce 10 different SISCDs [14, 33-52] useful for
CE enantiomer separations. Numerous asymmetrically substituted CD derivatives have
been produced using strategy iv). None are of the sulfated type and all offer low yields
since they typically use poorly regioselective reaction conditions to functionalize the C2
hydroxy group in the presence of an unprotected C3 hydroxy group [31, 53]. An
alternative to this strategy is to protect the C2 position as a silyl-ether that can be
removed without concurrent deprotection of the already protected C6 position.
Functionalization of the C2 position can then be conducted using a suitable electrophile
like iodomethane in the presence of sodium hydride. This allows desired
functionalization of the C2 position via an intra-glucosidic silyl-ether migration
mechanism [53-57]. Subsequent deprotection steps can then be conducted to allow
5functionalization of the C3 and C6 positions, independently of one another. This strategy
uses highly regioselective reaction conditions to potentially produce the first
unsymmetrically substituted SISCD in yields that are significantly higher than those
previously reported.
1.3 Use of SISCD’s for Enantiomer Separations by CZE
SISCDs have been proven to be reliable, effective means for robust CE
enantiomer separations methods [14,33]. Several SISCDs have been used to screen sets
of structurally similar chiral acids, bases, neutrals and ampholytics under variable CD
concentrations and pH conditions in aqueous [34-37] and methanolic [38-42]
background electrolytes (BGEs) as well as in hydro-organic media [43]. Heptakis(2,3-
di-O-acetyl-6-O-sulfo)cyclomaltoheptaose (HDAS) [36] and the corresponding dimethyl,
HDMS [46], and dihydroxy, HS [37], homologs were the first SISCDs used for such
chiral separations. Further research led to development of the analogous α- [34,44,45]
and γ-CD [47-50] derivatives. Another, heptakis(2-O-methyl-3,6-di-O-
sulfo)cyclomaltoheptaose (HMDS) [51,52], has also been shown to be effective the for
separation of pharmaceutically active weak bases and is thus far the only SISCD
unsymmetrically substituted at the 2- and 3-position of the CD backbone.
Observed migration of an enantiomer is the sum of the enantiomers effective
mobility (µeff) and the non-discriminate electroosmotic flow (µeo):
µobs = µeff + µeo                                                       (1)
where µobs is the observed mobility and defined as the constant of proportionality
6between the velocity (ν) of an ion in an applied electric field (E).
νobs = µobsEappl                                                        (2)
According to Stokes, mobility is a function of the ratio of ionic charge (z) to
hydrodynamic radius (a) and viscosity (η) of the BGE.
µ = zeo/6πηa                                                       (3)
where eo is the elementary charge constant.
Critical to rational method development for enantiomer separations is the
relationship between the effective mobility of the enantiomer and the concentration of
the SISCD. The Wren and Rowe model of enantiomer separations by CE showed that, in
the case of neutral cyclodextrins, there exists an optimum CD concentration equal to the
inverse root of the multiple of the two enantiomer-CD binding constants [58-61].
[C]opt = (K1K2)-½                                                  (4)
where K1 and K2 are CD binding constants for the two enantiomers. At the optimum CD
concentration the enantiomers exhibit a maxima in the mobility difference vs.
concentration plot. Initial trials using native β-CD and randomly methylated β-CD
showed good agreement with the predictions of the model. However, the model is overly
simplified and asserts that the mobilities of enantiomer-CD complexes are equal. Also,
the model is limited since it does not take into consideration the effects of other
parameters including pH, electric field strength or electroosmotic mobility. 
A more inclusive model proposed by Rawjee et al. takes into account the effect
of pH on separation selectivity [62-64]. This model proposes that there are three distinct
types of enantiomer separations: ionoselective, desionoselective and duoselective
7enantiomer separations. In each case, separation selectivity is a function of the infinite
dilution ionic mobilities of the free and complexed enantiomers, the equilibrium binding
constants, the acid dissociation constant of the enantiomers, the pH and the cyclodextrin
concentration. The model shows that categorizing separations of weakly acidic or weakly
basic enantiomer pairs in this manner aids the selection of the optimum pH conditions
and CD concentration of the BGE . 
1.3.1 The Greater Significance of the Electroosmotic Flow
In CE, electroosmotic flow is the bulk flow of the BGE in the presence of an
electric field due to a potential at the surface of the fused silica capillary referred to as
the zeta potential (ζ). The potential arises from an immobile net negative charge at the
capillary surface due to dissociation of the silanol groups formed in the hydrolysis of
fused silica . According to the Stern model [65,66], the magnitude of the surface
potential is greatest at the capillary surface and decays logarithmically with increasing
distance from the capillary surface. The same model proposes a shear plane between a
very tightly bound layer of solvated counterions immediately adjacent to the capillary
wall, referred to as the Helmholtz plane,  and a diffuse layer of solvated counterions with
an unbalanced surplus of mobile cations that extends radially from the capillary wall.
Under the influence of an applied electric field, the cationic counterions in the diffuse
layer migrate to the cathode. As they do, they drag with them their waters of hydration
resulting in a plug-like bulk flow toward the cathode with a velocity that is proportional
to the charge density at the shear plane (σ), the vacuum permittivity (εo), the applied
8electric field (E), and the BGEs dielectric constant (ε),  ionic strength (I), temperature
(T), and viscosity (η),
vEOF = E (σ/η)(εo εRT/IF2)½                                                 (5)
where vEOF is the velocity of the EOF and R and F are the gas law and Faradays
constants, respectively . This relation illustrates the importance of temperature control
over the time course of a separation.
The greater significance of the EOF as pertains to enantiomer separations lies
with the idea that if the electroosmotic mobility is equal in magnitude but opposite in
direction to the mobility of the more slowly migrating enantiomer then infinite resolution
of the enantiomers is possible. This notion was first incorporated in what is today known
as the charged chiral resolving agent migration model [67-71] or CHARM for short.
Predictions of CHARM are that enantiomer resolution increases with increasing applied
electric field (E), increasing capillary length (l), decreasing temperature (T) and as
separation selectivity (α) diverges away from unity,
                       (6)Rs
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where k is the Boltzman constant, eo is the fundamental charge and zeff is the effective
charge of the analyte. Here, separation selectivity (α) is defined as the ratio of the
effective mobilities of the two enantiomers,
α = µ1eff / µ2eff                                                                (7)
where subscripts one and two refer to the faster and slower enantiomers, respectively and
β is the electroosmotic mobility normalized to the effective mobility of the slower
9enantiomer,
β = µEO/ µ2eff                                                            (8)
The resolution equation reflects that at constant α and zeff, resolution approaches infinity
as the β value approaches -1 so that as long as α does not equal 1, resolution is possible.
Capillary coatings and BGE viscosity modifiers like hydroxymethylcellulose are used to
optimize the electroosmotic mobility for separations with α values that are very close to
unity.
1.3.2 Impact of Ionic Strength Effects on SISCD Enantiomer Separations
An appreciation of ionic strength effects in CE can be gained through an
understanding of the Debye-Huckel-Onsager theory and the model from which it is
derived. The model uses as its basis the Debye-Huckel theory of point charges. The
model is taken a step beyond in that it applies an electric field to the point charge and
observes that the spherical ionic cloud around the reference ion is distorted due to an
incomplete formation of the cloud in front of the migrating ion and an incomplete decay
of the ionic cloud behind the migrating ion. The result is an egg-shaped cloud with
charge center a finite distance behind the migrating ion. The deformed cloud exerts a
drag on the migrating ion in what is referred to as the relaxation effect. The result is that
mobilities decrease with increasing ionic strength. An empirical expression proposed by
Reijenga et al. [72-75] allows for use of CZE to measure directly the effect of ionic
strength on ionic mobility. The expression takes the form,
 µ = µο εξπ(−α(ζΙ)0.5)                                                   (9)
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where µo is the infinite dilution mobility, z is the charge and a is a constant that takes the
value a = 0.5 when z = 1 and a = 0.77 when z > 2. This equation was found to be valid in
the range 1 < I < 100mM for monovalent ions and the range 0 < I < 1 mM for
multivalent ions up to z = 6. Here, ionic strength is defined in the classic Lewis sense,
    I = 0.5Σci zi2                                                       (10)
The Reijenga equation was used to explain an unexpected mobility trend observed when
a 14-charged SISCD was used for the separation of weakly basic, pharmaceutically
active enantiomers [51]. The observation was that at zero SISCD concentration the
effective mobility of weakly basic enantiomers in a low pH BGE was positive and that
with increasing SISCD concentration the mobilities of the enantiomers became less
cationic until at some concentration a cationic mobility minima was passed. Further
increase in the SISCD concentration resulted in an increase in the cationic mobility of
the enantiomers over the SISCD concentration range used. Extrapolation of the model
showed that at higher concentrations the mobility will be depressed to zero mobility. The
same study showed that when the enantiomer binding constant is large (i.e. > 500) that
there is a local anionic mobility maximum that decreases on further increase in the
SISCD concentration until at some point the mobility can become very slightly cationic
and finally approach a zero mobility. The findings of this study suggest that without
further expansion of treatments like the Reijenga model to include more highly charged
species such as SISCDs (z > 6), equilibrium binding constants cannot be accurately
measured.
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1.4 Solvent Effects in CE
The BGE solvent should satisfy numerous criteria including i) liquid over a
suitable temperature range; ii) acceptably low viscosity; iii) solubility for electrolyte
components; iv) low to moderate volatility; v) chemical stability; vi) low UV-cutoff; vii)
sufficiently high dielectric constant; vii) compatibility with instrumentation. Water, of
course, satisfies all of these but so do numerous other solvents [76-78]. Other, somewhat
common, CE solvents are methanol [79-81], acetonitrile [82] and, to a lesser extent,
formamide [83]. There is much interest in the use of solvents other than water for CE
enantiomer separations since other solvents can provide higher solubility for
hydrophobic pharmaceuticals and effect differences in both mobilty [84-86] and
separation selectivity [87,88] compared to aqueous BGEs.
In CE, the primary role of the BGE is to buffer the pH of the separation medium
from change due to production of hydronium and hydroxide at the anode and cathode,
respectively, and to provide a conductive medium for separations [88]. When a potential
is applied to a BGE filled capillary, the current generated produces Joule heat that results
in greater band broadening and is counterproductive to separation. This catch-22
situation is worsened with high electric fields, a condition that favors enantiomer
resolution, since the temperature gradient across the capillary is proportional to the
square of both the electric field strength(E) and the capillary inner diameter (r),
Tdiff = E2κaver2 / 4ksol                                               (11)
where κave is the electrical conductivity of the BGE averaged over the capillary radius
and ksol is the thermal conductivity of the solvent [89,90]. It seems that the lower thermal
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conductivity of non-aqueous solvents, namely methanol (ksol = 0.2 WK-1m-1), might be
disadvantageous compared to water (ksol = .61 WK-1m-1) in CE. However, thermal band
broadening has been found to be negligible when the inner diameter of the capillary is 50
µm and less [91,92], as long as electrophoresis is carried out in the linear portion of
Ohms Law [93-94].
The principles governing resolution in CE in aqueous BGEs have shown to
apply to organic solvents as well as methanol. As previously discussed, ionic mobility
decreases with higher ionic strengths. Extension of Stokes mobility expression to
include the effecs of BGE permittivity, viscosity and ionic strength on mobility shows
                                        (12)µ µ
ε
µ
η ε
= − +





o T) o T
I
82 04
3
4 275.
(
.
that compared to aqueous solvents, the ionic strength induced mobility decrease in
organic solvents is approximately 3 and 4 times greater for MeOH and ACN solvents
over a 0.01 mol L-1 range in ionic strength. For CE enantiomer separations, this means
potentially dramatic changes in trends for separation selectivity.
Development of new chiral resolving agents allows for expansion of the number
of tools available to the modern day separation scientist. Cyclodextins are among the
most versatile chiral resolving agents since they are easily modified to produce different
structures capable of different intermolecular interactions with enantiomers. There are
currently no SISCDs asymmetrically substituted at all three hydroxy groups. It is the
purpose of this dissertation to report the synthesis, characterization and use of the first
 two such β-CD derivatives for enantiomer separations.
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CHAPTER II
SYNTHESIS AND CHARACTERIZATION OF
 SINGLE-ISOMER HMAS AND HMS
There are currently no reports on unsymmetrically substituted single-isomer
sulfated cyclodextrins in the literature. All species produced for use as chiral resolving
agents have been substituted at their C2 and C3 positions and/or at their C2 and C6
positions with identical functionalities. This dissertation describes the preparative- scale
synthesis of the first two unsymmetrically substituted SISCDs for use as chiral resolving
agents in capillary electrophoretic enantiomer separations: heptakis(2-O-methyl-3-O-
acetyl-6-O-sulfo)cyclomaltoheptaose sodium salt (HMAS) and heptakis(2-O-methyl-6-
O-sulfo)cyclomaltoheptaose sodium salt (HMS).
2.1 Materials and Methods
Native β-cyclodextrin was purchased from Cerestar, (Cedar Rapids, IA). Tert-
butyldimethylchlorosilane (TBS) was purchased from FMC Lithium Div. (Bessemer
City, NC). Triethylsilylchlorosilane (TES) was obtained from Gelest, Inc. (Morrisville,
PA). Imidazole (Im) was obtained from Chem Impex (Wood Dale, IL).
Dimethylaminopyridine (DMAP), sodium hydride (60% dispersion in mineral oil),
iodomethane, sodium fluoride and pyridine complexed sulfur trioxide and all BGE
components were purchased from Aldrich Chemical Co. (Milwaukee, WI). Hydrofluoric
acid, acetic anhydride and all reaction solvents were obtained from Mallinckrodt
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Chemical Co. (St. Louis, MO). Activated, 200-mesh, 4Å- molecular sieves from Fischer
Scientific, Inc. (Fairlawn, NJ) were used to dry the solvents. Aluminum backed silica-60
TLC plates from E.M. Science (Gibbstown, NJ) were used to monitor the progress of
reactions. A reagent solution composed of 35g α-napthol and 140 mL conc. sulfuric acid
in 500mL of an ethanol:water mixture (5.25:1) was used to visualize the cyclodextrin
spots. Visualization was accomplished by dipping the TLC plate in the reagent solution
and heating it in a 110º C oven for 10 minutes. Imidazolium chloride (ImHCl) produced
in the first and second synthetic transformations was isolated and recrystallized from
methanol: ethyl acetate until colorless.
An HPLC system consisting of a Beckman 126 solvent module equipped with
analytical pump heads, a Rheodyne 7125 injection valve (Rheodyne, Cotati, CA), a
Eurosep DDL-31 evaporative light scattering detector (ELSD) (Eurosep Instruments, St.
Christophe, France) set to 53º C and 400 gain and a Beckman 406 A/D converter
operated under Gold 8.1 chromatography software (Beckman-Coulter, Fullerton, CA) on
an IBM PS/2 PC was used to establish the purity of all intermediates. Separations were
carried out on 4.6mm i.d. x 250mm analytical columns packed with either 5 µm Luna
silica or 5µm Luna C18 stationary phases. All ELSD response factors were assumed to
be equal.
The isomeric distribution of the final products was analyzed using a Beckman
P/ACE 2100 capillary electrophoresis system equipped with a UV detector operated at
214 nm, a 46cm long, 25µm i.d. bare fused silica capillary (injector to detector length 39
cm) (Polymicro Technologies, Phoenix, AZ), at 20kV separation potential and (-) to (+)
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polarity. The BGE used was 30mM β-alanine titrated to pH 3.5 with para-toluenesulfonic
acid. The reaction was sampled while in progress, diluted with the BGE and the solution
was injected for 1 sec at 1 p.s.i. before application of the separation potential. All
analyses were completed at 20º C.
1-D 1H, 13C and DEPT NMR experiments were done on a Varian 500MHz
UnityPlus Spectrometer (Varian Assoc., Walnut Creek, CA) equipped with a 1H/13C dual
tunable probe using VnmrX 5.3b software running on a SUN workstation. 2-D
experiments including double quantum filtered 1H-1H correlation spectroscopy (DQ-
COSY) and 1H-13C heteronuclear correlation spectroscopy (HETCOR) were obtained on
either the same 500MHz UnityPlus Spectrometer or on a Varian 300 MHz UnityPlus
spectrometer equipped with 1H/ 19F/ 31P/ 13C quad probe and Solaris 2.4 software running
on a SUN workstation.
High-resolution MALDI-TOF mass spectra were obtained with a Voyager-DE
STR Biospectrometry Workstation equipped with delayed extraction capability
(Perseptive Biosystems, Framingham, MA) with the following instrument settings:
nitrogen laser (λ= 337 nm), reflectron mode, 25 kV acceleration voltage, 70% grid
voltage and 180 µs delay time. The mass spectra from 100 laser pulses were averaged to
achieve adequate signal-to-noise ratio. All samples were prepared by dissolving 10 mg of
2,4,6-trihydroxyacetophenone (THAP) in 1 mL HPLC grade acetonitrile and 10 mg of
the cyclodextrin derivative to be analyzed in 1 mL of  either CH2Cl2 or water, along with
10 mg of an internal standard, heptakis(2-O-methyl)cyclomaltoheptaose. Equal volumes
of these solutions were combined and 10 µL applied to a PTFE target stage and allowed
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to dry [110].
Crystal structures were obtained on a Bruker SMART 1000 X-ray Diffractometer
(Bruker AXS, Madison, WI) from single crystals grown in suitable solvents. Diffraction
patterns were solved and refined using the SHELLXTL program suite running on a
Pentium III 300 MHz processor PC. Crystal structure and Connelly surface figures were
generated using the Insight II molecular modeling software package running on an SGI
O2 workstation.
2.2 Synthesis and Characterization
For silylation, the C6 hydroxy group of β-CD reacts first followed by the C2
hydroxy group and then the C3 hydroxy group. Thus, selective silylation can be
achieved, but not without the formation of some undesirably substituted species. The
implication is that the reaction products will need to be purified at every stage of the
multi-step synthetic scheme on a scale sufficient to produce 50-250g of final products for
CZE enantiomer separations.
The synthetic scheme shown in Figure 1 makes use of regioselective protecting
group chemistry and orthogonally deprotectable functionalities to produce HMAS and
HMS in high yield. The details of the synthetic procedure are outlined in Appendix A.
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Figure 1. Synthetic scheme for HMAS and HMS.
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2.2.1 Heptakis(6-O-t-butyldimethylsilyl)cyclomaltoheptaose
The primary hydroxy groups at the C6 positions of β-CD were reacted in DMF at
room temperature with TBS dissolved in ethyl acetate according to a modified Takeo
procedure [44]. Reaction progress was monitored using a 5µm Luna, C18 RP-HPLC
column with a 40:60 MeOH:EtOAc isocratic mobile phase at 2 mL/min. The reaction
solution was allowed to stir for 10 hrs after completion of TBS addition. The ImHCl
precipitate was filtered and the reaction solvent removed under reduced pressure. The
crude material was recrystalized four times from a DMF/ acetone/ water ternary solvent
mixture and dried in vacuo. This reaction was scaled to 2.0 kg and repeated once more to
produce 4.78 kg of white powder with an isomeric purity of 99.5% (70% yield) . Figure
2 is a chromatogram of the crude product overlaid with a chromatogram of the final
recrystallized product.
Full 1H and 13C analyses are shown in Figures 3 and 4, respectively. Peak
assignments for 1H and 13C NMR spectra are made from 1-dimensional DEPT and 2-
dimensional 1H- 1H homonuclear correlation spectroscopy (COSY) and 1H- 13C
heteronuclear correlation spectroscopy (HETCOR) experiments. NMR data (CDCl3):1H,
δ 5.49 (broad, exchangeable, HO-2 and HO-3), δ 4.89 (d, 7 H, J1,2 3.5 Hz, H-1),  δ 4.03
(t, 7H, J3,4 9.0 Hz, H-3),  δ 3.90 (d, 7H, J6,6' 10.8 Hz, H-6), δ 3.71 (d, J6',6 10.8 Hz, H-6'6),
δ 3.63 (m, 14 H, H-2,5), δ 3.55 (t, 7 H, J4,3 9.0 Hz, H-4), 0.86 (s, 63 H,
Si(CH3)2(C(CH3)3)), δ 0.04 and δ 0.03 (2×s, 42 H, Si(CH3)2(C(CH3)3); 13C δ 102.22 (C-
1), δ 81.94 (C4), δ 73.80 (C2), δ 73.64 (C3), δ 72.75 (C5), δ 61.85 (C6), δ 26.13
(Si(CH3)2(C(CH3)3), δ 18.49 (Si(CH3)2(C(CH3)3), δ - 4.85 (Si(CH3)2(C(CH3)3), δ - 4.97 
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Figure 2. Overlay of A) chromatogram of crude (2) and B) chromatogram of
recrystallized (2).
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Figure 3. A) 1H and B) 1H-1H COSY spectra of (2) in CDCl3.
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Figure 4. A) DEPT B) 13C and C) 1H- 13C HETCOR spectra of (2) in CDCl3.
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(Si(CH3)2(C(CH3)3). 1H-1H COSY and 1H-13C HETCOR spectra show only the signals
corresponding to the CD backbone. DEPT analysis is included to allow easy assignment
of silyl-ether carbons. The TBS ether tertiary carbon signal is fully suppressed in the
DEPT spectrum and the C6 methylene group is identified as the only negative-going
signal. The t-butyl methyl signal is upfield of the signal for the diastereotopic methyl
group attached directly to silicon. The HETCOR spectrum shows both diastereotopic H6
hydrogens coupled to C6 in the methylene group. 
High resolution MALDI-TOF mass spectrometry was used to determine the
molecular weight of intermediate (2). The MALDI-TOF-MS spectrum of the sodium and
potassium adducts of  (2) is shown in Figure 5. The measured m/z values of 1955.55 and
1971.32 agree well with the value calculated for the monoisotopic sodium and potassium
adducts, 1955.96 and 1971. 94, respectively.
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Figure 5. A section of the MALDI-TOF-MS mass spectrum of (2).
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2.2.2 Heptakis(2-O-triethylsilyl-6-O-t-butyldimethylsilyl)cyclomaltoheptaose
Attempts to use a trimethylsilyl (TMS) ether as a protecting group for the C2
hydroxyl groups failed due to poor regioselectivity over the C3 hydroxyl groups. 
Instead, the secondary hydroxy groups at the C2 position were reacted in THF at room
temperature with TES dissolved in ethyl acetate. The reaction progressed with excellent
regioselectivity as can be seen in the chromatogram shown in Figure 6 of a sample taken
from the reaction vessel prior to quenching. The reaction was monitored using a 5µm
Luna, C18 RP-HPLC column and gradient elution at 2 mL/min with a mobile phase that
begins with 40:60 MeOH:EtOAc and after six minutes changes linearly to 100% EtOAC,
in 30 minutes. The very high regioselectivity of TES for the C2 hydroxyl groups is likely
due to steric hindrance at the C3 hydroxyl groups. The reaction solution was allowed to
stir for 10 hrs after completion of TESCl addition. The ImHCl precipitate was filtered
and the reaction solvent removed under reduced pressure. The crude material was
digested twice in acetone and dried in vacuo. This reaction was scaled to 1.0 kg to
produce 1.36 kg of white powder with an isomeric purity of 99.8% (96% yield).
Full 1H and 13C analyses are included in Figures 7 and 8, respectively. Peak
assignments for 1H and 13C NMR spectra are made from 1-dimensional DEPT and 2-
dimensional 1H- 1H COSY and 1H- 13C HETCOR experiments. NMR data (CDCl3): 1H δ
4.81 (d, 7H, J1,2 3.5 Hz, H-1), δ 4.72 (s, 7H, HO-3), δ 3.94 (dd, 7H, J6,6' 11.5 Hz, J6,5 3.1
Hz, H-6), δ 3.82 (t, 7H, J3,2= J3,4 9.3 Hz, H-3), δ 3.67 (d, 7H, J6',6 11.5 Hz, H-6'), δ 3.60
(d, 7H, J5,4 11.5 Hz, H-5), δ 3.50 (dd, 7H, J2,3 9.3 Hz, J2,1 3.5 Hz, H-2), δ 3.43 (t, 7H, J4,3=
J4,5 9.3 Hz, H-4),δ 0.97 (t, 63H, J8,7 7.9 Hz, Si(CH2CH3)3),δ 0.87 (s, 63H, 
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Figure 6. HPLC-ELSD chromatogram of (3) obtained for a 1-kg batch prior to quenching
of the reaction.
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Figure 7. A) 1H and B) 1H-1H COSY spectra of (3) in CDCl3.
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Si(CH3)2(C(CH3)3), δ 0.76 and δ 0.67 (2 × sextet, 42H, J7,7 15.8 Hz, Si(CH2CH3)3), δ
0.03 and 0.02 (2 × s, 63H, Si(CH3)2(C(CH3)3); 13C δ 102.88 (C-1), δ 82.41 (C4), δ 74.93
(C2), δ 72.35 (C3), δ 72.20 (C5), δ 62.15 (C6), δ 26.09 (Si(CH3)2(C(CH3)3), δ 18.51
(Si(CH3)2(C(CH3)3), δ 6.93 (Si(CH2CH3)3), δ 4.81 (Si(CH2CH3)3), δ - 4.84
(Si(CH3)2(C(CH3)3), δ - 5.01 (Si(CH3)2(C(CH3)3). The 1H-1H COSY and 1H-13C
HETCOR spectra show only the signals corresponding to the CD backbone. The two
sextets in the 1H NMR spectrum are for the diastereotopic TES ether methylene
hydrogens. The expected doublet of quartets for each hydrogen is not observed because
of inadequate resolution. DEPT analysis is included to allow easy assignment of silyl-
ether carbons. The signals for the TES ether methyl and methylene groups are between
the signals for the TBS tertiary and diastereotopic carbon atoms. The negative going
peak corresponds to the methylene group. 
A portion of the high resolution MALDI-TOF-MS spectrum of (3) is shown in
Figure 9. The measured m/z values of 2754.82 and 2770.79 agree well with the value
calculated for the monoisotopic sodium and potassium adducts, 2754.82 and 2770.79,
respectively.  
During development of the TES protection step, acetone was not the first solvent
used for digestion. The first used was anhydrous ethanol which resulted in removal of
the TES groups as suggested by the RP-HPLC-ELSD chromatogram shown in Figure 10.
Here, seven peaks are visible where the latest eluting peak is the fully TES substituted
derivative. The earlier eluting peaks are successively deprotected species having had one
or more TES groups removed. At the time of this experiment, the reaction conditions
29
Figure 9. A section of the MALDI-TOF-MS mass spectrum of (3).
still included DMF as a part of the reaction solvent. Aqueous extraction was required to
remove the dissolved ImHCl. It was shown that the small amount of ImHCl remaining
after extraction and slightly wet conditions was responsible for the silyl loss. 
30
Figure 10. RP-HPLC chromatogram of partially deprotected (3) obtained from ethanol
digestion in the presence of ImHCl and water contaminants.
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2.2.3 Heptakis(2-O-methyl-3-O-triethylsilyl-6-O-t-butyldimethylsilyl)cyclomalto-
heptaose
Methylation of (3) was accomplished in THF at room temperature using
iodomethane in the presence of sodium hydride, in 4 hrs, to obtain (4) at 97%
conversion. This reaction was conducted on the 500 g scale and repeated twice. Reaction
progress was monitored using a 5µm Luna, C18 RP-HPLC column with a 30:70
MeOH:EtOAc isocratic mobile phase at 2 mL/min. Upon completion, the reaction was
quenched with MeOH. After stirring for an additional half-hour, hexanes were added and
sodium iodide was extracted with water. The hexanes were removed under reduced
pressure and the crude recrystallized four times from acetone and dried in vacuo to yield
563g (92% yield) of (4) as a white powder at a 99.8% isomeric purity. Shown in Figure
11 is an overlay of the RP-HPLC chromatograms for the recrystallized reaction product
before (trace A) and after (trace B) recrystallization from acetone.
Full 1H and 13C analyses are included in Figures 12 and 13, respectively. Peak
assignments for 1H and 13C NMR spectra are made from 1-dimensional DEPT and 2-
dimensional 1H- 1H COSY and 1H- 13C HETCOR experiments. NMR data (CDCl3): 1H δ
5.27 (d, 7H, J1,2 3.5 Hz, H-1), δ 4.22 (d, 7H, J6,6' 12.0 Hz, H-6), δ 4.02 (t, 7H, J3,2 = J3,4
8.0 Hz, H-3), δ 3.81 (t, 7H, J4,3 = J4,5 8.0 Hz, H-4), δ 3.66 (m, 14H, H-5,6'), δ 3.36 (s,
21H, Methyl ether), δ 2.99 (dd, 7H, J2,1 3.5 Hz, J2,3 8.0 Hz, H-2), δ 0.96 (t, 63H, J9,8 7.7
Hz, Si(CH2CH3)3), δ 0.89 (s, 63H, Si(CH3)2(C(CH3)3), δ 0.68 (doublet of quartets, J8,8 3.0
Hz, Si(CH2CH3)3),  δ 0.034 and 0.030 (2 × s, 63H, Si(CH3)2(C(CH3)3); 13C δ 96.55 (C-1),
δ 81.75 (C2), δ 78.49 (C4), δ 73.36 (C3), δ 71.98 (C5), δ 62.95 (C6), δ 57.11 (CH3O),
32
Figure 11. HPLC-ELSD chromatogram of (4) A) before and B) after recrystallization.
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Figure 12. A) 1H and B) 1H-1H COSY spectra of (4) in CDCl3.
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Figure 13. A) DEPT B) 13C and C) 1H- 13C HETCOR spectra of (4) in CDCl3.
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δ 26.23 (Si(CH3)2(C(CH3)3), δ 18.54 (Si(CH3)2(C(CH3)3), δ 7.37 (Si(CH2CH3)3), δ 5.47
(Si(CH2CH3)3), δ - 4.45 and - 4.83 (Si(CH3)2(C(CH3)3).
1H-1H COSY and 1H-13C HETCOR spectra show only the signals corresponding
to the CD backbone. The signal for the TES ether diastereotopic protons has collapsed to
two nearly overlapping quartets. The J-coupling constant for the two almost magnetically
equivalent diastereotopic protons is much smaller after than before migration of the TES
group from the C2 hydroxy to the C3 hydroxy. Silyl migration is also indicated in the
13C- NMR spectrum where the signal for the C2 nucleus is shifted downfield (less
shielded) after substitution with the methyl group.
 High resolution MALDI-TOF mass spectrometry was used to determine the
molecular weight of intermediate (4). The MALDI-TOF-MS spectrum of the sodium and
potassium adducts of  (4) is shown in Figure 14. The measured m/z values of 2852.70
and 2868.67 agree well with the value calculated for the monoisotopic sodium and
potassium adducts, 2852.68 and 2868.65, respectively. 
36
Figure 14. A section of the MALDI-TOF-MS mass spectrum of (4).
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2.2.4 Heptakis(2-O-methyl-6-O-t-butyldimethyl)cyclomaltoheptaose
Selective deprotection of (4) was accomplished by stirring with ImHCl in a 35:65
MeOH: THF solution, under reflux for 6 hrs, to give (5) with 96% conversion. This
reaction was conducted at the 1-kg scale and repeated once. Reaction progress was
monitored using a 5µm Luna, C18 RP-HPLC column and gradient elution at a flow rate
of 2 mL/min with a  mobile phase that begins with 35:65 MeOH:EtOAc and after nine
minutes changes linearly to 90% EtOAC, in 6 minutes. Once judged complete, the
reaction solvent was removed under reduced pressure and the crude redissolved in
EtOAc. Next, ImHCl was filtered and EtOAc removed under reduced pressure. The
crude product was extracted with 2 × 100-mL water and recrystallized twice from 50:50
MeOH:EtOAc and dried in vacuo to yield 546 g (76% yield) of (5) as a white powder at
99.6% isomeric purity (m.p. 257.0- 257.5 º C). Shown in Figure 15 is an overlay of the
RP-HPLC chromatograms of the product after recrystallization and the recrystallization
mother liquor.
Full 1H and 13C analyses are included in Figures 16 and 17, respectively.  Peak
assignments for 1H and 13C NMR spectra were made from 1-dimensional DEPT and 2-
dimensional 1H- 1H double-quantum filtered COSY and 1H- 13C HETCOR experiments.
NMR data (CDCl3): 1H δ 5.07 (exchangeable, HO-3), δ 4.96 (d, 7H, J1,2 3.7 Hz, H-1), δ
3.95 (t, 7H, J3,2 = J3,4 9.5 Hz, H-3), δ 3.93 (d, 7H, J6,6' 9.0 Hz, J6,5 2.6 Hz, H-6), δ 3.67 (d,
7H,  J6',6 9.0 Hz, H-6'), δ 3.65 (s, 21H, CH3O-), δ 3.57 (d, 7H, J5,4 9.5 Hz, H-5), δ 3.52 (t,
7H, J4,2 = J4,3 9.5 Hz, H-4), δ 3.18 (dd, 7H, J2,3 9.5, J2,1 3.5 Hz, H-2), δ 0.89 (s, 63H,
Si(CH3)2(C(CH3)3), δ 0.048 and δ 0.039 (2× s, 42H, Si(CH3)2(C(CH3)3); 13C δ 100.83 (C-
38
Figure 15. HPLC-ELSD chromatogram of (5) A) recrystallization mother liquor and B)
after recrystallization.
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Figure 16. A) 1H and B) 1H-1H double-quantum filtered COSY spectra of (5) in CDCl3.
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Figure 17. A) DEPT B) 13C and C) 1H- 13C HETCOR spectra of (5) in CDCl3.
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1), δ 82.52 (C2), δ 82.41 (C4), δ 73.35 (C3), δ 71.92 (C5), 61.87 (C6), δ 60.35
(Si(CH3)2(C(CH3)3). 1H-1H double-quantum filtered COSY and 1H-13C HETCOR spectra
show only the signals corresponding to the CD backbone. The 1H and 13C NMR spectra
indicate that the TES group has been selectively removed without removal of the TBS
protecting group. The COSY spectrum indicates that the exchangeable proton is coupled
to the proton at the C3 position, as expected.
 A portion of the high resolution MALDI-TOF-MS spectrum of (5) is shown in
Figure 18. The measured m/z values of 2053.26 and 2069.05 agree well with the value
calculated for the monoisotopic sodium and potassium adducts, 2054.07 and 2070.05,
respectively.
Conditions reported in the literature for selective removal of TES in the presence
of TBS failed to produced the selectively deprotected derivative with high conversion
rate. Tested conditions included use of AcOH in pyridine, several dilute concentrations
of HF and NaF in MeOH and several dilute concentrations of HCl in THF. Conditions
using AcOH were ineffective, resulting in no deprotection. Conditions using HF/NaF
and those using HCl showed no selectively between TES and TBS deprotection. It was at
this time that efforts were put toward development of TES deprotection in the presence
of ImHCl. Initial experiments showed that a protic solvent was required and for this
MeOH was chosen.. The reaction is thought to follow the acid catalyzed mechanism
shown in Figure 19. The proposed mechanism is simply the reverse of the protection
mechanism except that the chloride anion is substituted for methoxide. The scheme was
supported by GC-MS analysis of the reaction mixture where triethylmethoxysilane was
42
Figure 18. A section of the MALDI-TOF-MS mass spectrum of (5).
identified as a major constituent.
Figure 20 is a plot of the change in the log of the area ratio of (3) to an internal
standard versus the concentration of ImHCl as measured by RP-HPLC-ELSD for five
individual deprotection reactions, each successively higher in ImHCl concentration. The
linear relationship was used to project the ImHCl concentration required to accomplish
the reaction in twelve hours. Reaction conditions were then altered to include a
MeOH/THF co-solvent so that the multiple of the concentrations of ImHCl, (3) and
MeOH could be set to a maximum. This allowed reaction completion in six hours.
Finally, anhydrous conditions were found to afford (4) with highest conversion.
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Figure 19. Possible deprotection mechanism.
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Figure 20. Progress of desilylation as a function of ImHCl concentration.
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2.2.5 Heptakis(2-O-methyl-3-O-acetyl-6-O-t-butyldimethylsilyl)cyclomaltoheptaose
Acetylation of (5) was carried out in pyridine at 50º C for 32 hrs, in the presence
of excess acetic anhydride. This reaction was scaled to 0.5 kg. Reaction progress was
monitored using two separate sets of chromatographic conditions. A 5µm Luna, C18 RP-
HPLC column and a 2 mL/min, 55:45 EtOAc:MeOH isocratic mobile phase was used to
quantify the amount of desilylated side-products relative to the amount of all other
species. A 5µm Luna, NP-HPLC silica column and gradient elution at a flow rate of 2
mL/min using a mobile phase that begins at 95:5 CHCl3:MeOH and changes to 100%
MeOH in 7 min. was used to quantify the amount of under-acetylated species relative to
the amount of all other species. The proportion of the amount of target to all other
species was calculated from the values obtained by the two different methods. Upon
completion,  the reaction solvent and acetic acid by-product were removed under
vacuum. The crude solid was redissolved in hexanes and purified via counter-current
extraction with DMF. The target was concentrated in the hexanes phase while all other
species were concentrated in the DMF phase. The hexanes were removed under reduced
pressure and the product dried in vacuo to yield 522 g (91% yield) of (6) as a white
powder at 99.4% isomeric purity. Figure 21 shows the RP-HPLC chromatogram of the
hexanes extract obtained from the counter-current extraction process.
Full 1H and 13C analyses are included in Figures 22 and 23, respectively. Peak
assignments for 1H and 13C NMR spectra were made from 1-dimensional DEPT and 2-
dimensional 1H- 1H COSY and 1H- 13C HETCOR experiments. NMR data (CHCl3): 1H δ
5.12 (t, 7H, J3,2 = J3,4 9.3 Hz, H-3), δ 5.07 (d, 7H, J1,2 3.5 Hz, H-1), δ 4.13 (dd, 7H, J6,6' 
46
Figure 21. HPLC-ELSD chromatogram of (6) after counter-current extraction.
47
3.2
3.6
4.0
4.4
4.8
5.2
F1
(ppm)
3.23.64.04.44.85.2
F2 (ppm)
H1
H2
H3
H4, H5 H6b
H6a
Me Ac
7.0
7.0 7.0 7.0
14.0
21.07.021.0 63.0 42.0
5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
Figure 22. A) 1H and B) 1H-1H COSY spectra of (6) in CDCl3.
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Figure 23. A) DEPT B) 13C and C) 1H- 13C HETCOR spectra of (6) in CDCl3.
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11.0 Hz, J6,5 2.0 Hz, H-6), δ 3.78 (t, 7H, J4,5 = J4,3 9.3 Hz, H-4), δ 3.74, (d, 7H, J5,4 9.3 Hz,
H-5), δ 3.67 (d, 7H, J6',6 11.0 Hz, H-6'), δ 3.36 (s, 21H, CH3O-), δ 3.12 (dd, 7H, J2,3 9.3
Hz, J2,3 9.3 Hz, J2,1 3.5 Hz, H-2), δ 2.09 (s, 21H, CH3CO-), δ 0.90 (s, 63H,
Si(CH3)2(C(CH3)3), δ 0.046 and 0.044 (2 × s, 42H, Si(CH3)2(C(CH3)3); 13C δ 170.31
(CH3CO-), δ 98.55 (C-1), δ 80.07 (C2), δ 77.36 (C5), δ 73.45 (C3), δ 72.35 (C4), δ 62.26
(C6), δ 58.70 (CH3O-), δ 26.10 (Si(CH3)2(C(CH3)3), δ 21.20 (CH3CO-), δ 18.50
(Si(CH3)2(C(CH3)3), δ- 4.73 and - 5.06 (Si(CH3)2(C(CH3)3).
1H-1H COSY and 1H-13C HETCOR spectra show only the signals corresponding
to the CD backbone. Upfield shift of the H-3 signal in the proton NMR confirms
acetylation at the C3 hydroxy group. The 13C NMR shows a broad weak signal for the C3
carbon. A likely explanation is that conformational change about the C3 carbons is slow
on the NMR time scale. The same spectral feature was not observed in deuteroacetone
(CD6CO). NMR analysis was conducted in CDCl3 because better spectral resolution was
observed in the 1H spectrum. 
A portion of the high resolution MALDI-TOF-MS spectrum of (6) is shown in
Figure 24. The measured m/z values of 2348.26 and 2364.26 agree well with the value
calculated for the monoisotopic sodium and potassium adducts, 2348.14 and 2364.13,
respectively. X-ray crysallographic data were collected from a single crystal of (6) grown
from EtOAc. Shown in Figure 25 are the stick representation and the Connelly solvent
surface of (6). Clearly, the substitution pattern is as expected. The Connelly solvent
surface shows that the cavity diameter of (6) in the crystal is approximately 8-12Å.
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Figure 24. A section of the MALDI-TOF-MS mass spectrum of (6).
.
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Figure 25. X-ray crystal structure of (6) in stick (top) and Connelly solvent surface
(bottom) representations.
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2.2.6 Heptakis(2-O-methyl-3-O-acetyl)cyclomaltoheptaose
Deprotection of (6) was done using hydrofluoric acid and sodium fluoride in
MeOH at 50º C in 72 hrs. The reaction was monitored using a 5µm Luna, C18 RP-HPLC
column and gradient elution at a flow rate of 2 mL/min with a mobile phase that begins
at 95:5 H2O:THF and changes in twelve minutes to 25:75 H2O:THF for five minutes.
Once desilylation was complete, the reaction solvent was removed under reduced
pressure and the product redissolved in CH2Cl2. Sodium fluoride was filtered and the
solvent volume reduced. The  crude product was then four times digested in 1.5 L diethyl
ether to yield 314 g (96% yield) of (7) as a white powder at 99.4% isomeric purity.
Shown in Figure 26 is the RP-HPLC chromatogram (7) after digestion in diethyl ether.
Full 1H and 13C analyses are included in Figures 27 and 28, respectively. Peak
assignments for 1H and 13C NMR spectra were made from 1-dimensional DEPT and 2-
dimensional 1H- 1H COSY and 1H- 13C HETCOR experiments. NMR data (D2O): 1H δ
5.11 (t, 7H, J3,4 10.0, H-3), δ 5.06 (d, 7H, J1,2 3.5 Hz, H-1), δ 3.83 (dd, 14H,  J6,6' 12.5 Hz,
J6,5 3.5 Hz, H-6), δ 3.78 (m, H-5,6'), δ 3.67 (t, 7H, J4,310.0 Hz, H-4), δ 3.30 (m, 21H, H-2,
CH3O-), δ 2.0 (s, 21H, CH3CO-); 13C δ 173.22 (CH3CO-), δ 98.26 (C-1), δ 78.92 (C2), δ
77.39 (C4), δ 73.06 (C3), δ 71.91 (C5), δ 60.38 (C6), δ 58.67 (CH3O-), δ 20.85
(CH3CO).  1H-1H COSY and 1H-13C HETCOR spectra show only the signals
corresponding to the CD backbone.
A portion of the high resolution MALDI-TOF-MS spectrum of (7) is shown in
Figure 29. The measured m/z values of 2348.26 and 2364.26 agree well with the value
calculated for the monoisotopic sodium and potassium adducts, 2348.14 and 2364.13, 
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Figure 26. HPLC-ELSD chromatogram of (7) after diethyl ether digestion.
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Figure 27. A) 1H and B) 1H-1H COSY spectra of (7) in D2O.
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Figure 28. A) DEPT B) 13C and C) 1H- 13C HETCOR spectra of (7) in D2O.
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Figure 29. A section of the MALDI-TOF-MS mass spectrum of (7).
from EtOAc. Shown in Figure 30 are the stick representation and the Connelly solvent
surface of (7). Clearly, the substitution pattern is as expected, and the Connelly solvent
surface shows a cavity diameter of approximately 8-12Å for (7).
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Figure 30. X-ray crystal structure of (7) in stick (top) and Connelly solvent surface
(bottom) representations.
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2.2.7 Heptakis(2-O-methyl-3-O-acetyl-6-O-sulfo)cyclomatoheptaose
Sulfation of (7) was conducted in DMF at room temperature with an excess of
pyridine complexed sulfur trioxide. Reaction completion was monitored using indirect-
UV CE with a BGE consisting of 30 mM β-alanine titrated to pH 3.5 with para-
toluenesulfonic acid. Polarity was set (-) to (+), across a 46 cm long, 25 µm I.D. capillary
(39 cm to detector) with 20 kV potential and detection at 214 nm. After 1 hr stirring, the
reaction was quenched with sodium bicarbonate and sodium sulfate filtered. DMF was
removed under reduced pressure, the crude material dissolved in a minimum volume of
MeOH and precipitated by pouring it into diethylether. This was repeated four to six
times or until all DMF traces were removed as indicated by proton NMR. The remaining
sodium sulfate was removed by dissolving the product at concentration of 50 mM in
MeOH and filtering. MeOH was removed under reduced pressure and the product was
redissolved in water which was removed under reduced pressure. This procedure was
scaled to 200 g. The product was dried in vacuo to give 276 g (94% yield) of (8) as a
white powder that was >97% isomerically pure. The indirect-UV CE trace of (8) is
shown in Figure 31.
Full 1H and 13C analyses are included in Figures 32 and 33, respectively. Peak
assignments for 1H and 13C NMR spectra were made from 1-dimensional DEPT and 2-
dimensional 1H- 1H COSY and 1H- 13C HETCOR experiments. NMR data (D2O): 1H δ
5.17 (d, 7H, J1,2 3.5 Hz, H-1), δ 5.14 (t, 7H, J3,4 = J4,5 9.4 Hz, H-3), δ 4.42 (d, 7H, J6,6'
11.0 Hz, H-6), δ 4.19 (d, 7H, J6',6 11.0 Hz, H-6'), δ 3.98 (d, 7H, J5,4 9.4 Hz, H-5), δ 7H,
J4,3 = J4,5 9.4 Hz, H-4), δ 3.34 (m, 28H, H-2, CH3O-), δ 2.04 (s, 21H, CH3CO-); 13C δ 
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Figure 31. Indirect UV-detection CE of HMAS. Conditions: 30 mM β-alanine titrated to
pH 3.5 with para-toluenesulfonic acid. Polarity was set (-) to (+), Ld/ Lt = 39.6/ 46.4 cm,
20 kV, (+) to (-) polarity.
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Figure 32. A) 1H and B) 1H-1H COSY spectra of (8) in D2O.
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Figure 33. A) DEPT B) 13C and C) 1H- 13C HETCOR spectra of (8) in D2O.
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Figure 34. A section of the MALDI-TOF-MS mass spectrum of (8).
173.28, δ 97.78 (C-1), δ 78.72 (C2), δ 76.35 (C4), δ 72.66 (C3), δ 70.19 (C5), δ 67.10
(C6), δ 58.69 (CH3O-), δ 20.85 (CH3CO-). 1H-1H COSY and 1H-13C HETCOR spectra
show only the signals corresponding to the CD backbone. Selective deprotection of the
C6 hydroxy group occurred without concurrent deacetylation as is evident in the proton
spectrum integration values. 
A portion of the high resolution MALDI-TOF-MS spectrum of (8) is shown in
Figure 34. The measured m/z value of 2263.11agrees well with the value calculated for
the monoisotopic sodium adduct, 2263.58. No potassium adduct was observed.
Ionization of a potassium adduct was likely suppressed due to the abundance of sodium
in the sodium salt of the final product.
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2.2.8 Heptakis(2-O-methyl-3-hydroxy-6-O-sulfo)cyclomaltoheptaose
Deacetylation of (8) was carried out under basic aqueous conditions. Completion
of the reaction was monitored using indirect-UV CE with a BGE consisting of 30 mM β-
alanine titrated to pH 3.5 with para-toluenesulfonic acid. Polarity was set (-) to (+),
across a 46 cm long, 25 µm I.D. capillary (39 cm to detector) with 20 kV potential and
detection at 214 nm. After 3 hr stirring, the volume of the reaction mixture was reduced
under reduced pressure to produce a viscous solution. The crude product was
precipitated by pouring it into anhydrous isopropanol (IPA). This was  repeated six times
to complete removal of acetate as indicated by indirect-UV CE analysis using a BGE that
was 30-mM in THAM titrated to pH 8.1 with para-toluenesulfonic acid. Other conditions
were as in Section 2.2.7. Shown in Figure 35 is the indirect-UV CE trace of (9) after
precipitation from water/IPA. This reaction was scaled to 100 g. The product was dried
in vacuo to give 60 g (65% yield) of (9) as a white powder that was >97% isomerically
pure.
Full 1H and 13C analyses are included in Figures 36 and 37, respectively.  1H-1H
COSY and 1H-13C HETCOR spectra show only the signals corresponding to the CD
backbone. Peak assignments for 1H and 13C NMR spectra were made from 1-dimensional
DEPT and 2-dimensional 1H- 1H COSY and 1H- 13C HETCOR experiments. NMR data
(D2O): 1H δ 5.53 (d, 7H, J1,2 3.5, H-1), δ 4.41 (d, 7H, J6,6' 10.5 Hz, H-6), δ 4.30 (d, 7H,
J6',6 10.5 Hz, H-6'), δ 4.17 (d, 7H, J5,4 10.0 Hz, H-5), δ 4.05 (t, 7H, J3,2 = J3,4 10.0 Hz, H-
3), δ 3.81 (t, 7H, J4,3 = J4,5 10.0 Hz, H-4), δ 3.58 (s, 21H, CH3O-), δ 3.37 (dd, 7H, J2,1 3.5
Hz, J2,3 10.0 Hz, H-2); 13C δ 97.03 (C-1), δ 81.17 (C2), δ 77.54 (C4), δ 71.99 (C3), δ 
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Figure 35. Indirect UV-detection CE of HMAS. Conditions: 30 mM β-alanine titrated to
pH 3.5 with para-toluenesulfonic acid. Polarity was set (-) to (+), Ld/ Lt = 39.6/ 46.4 cm,
20 kV, (+) to (-) polarity.
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Figure 36. A) 1H and B) 1H-1H COSY spectra of (9) in D2O.
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Figure 37. A) DEPT B) 13C and C) 1H- 13C HETCOR spectra of (9) in D2O.
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Figure 38. A section of the MALDI-TOF-MS mass spectrum of (9).
68.78 (C5), δ 66.78 (C6), δ 58.94 (CH3O-). 1H-1H COSY and 1H-13C HETCOR spectra
show only the signals corresponding to the CD backbone.
A portion of the high resolution MALDI-TOF-MS spectrum of (9) is shown in
Figure 38. The measured m/z value of 1969.29 agrees well with the value calculated for
the monoisotopic sodium adduct, 1969.04. Little potassium adduct was observed.
Ionization of a potassium adduct was likely suppressed due to the abundance of sodium
in the sodium salt of the final product.
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2.4 Summary
The large-scale synthesis of the sodium salts of HMAS and HMS for use as chiral
resolving agents in capillary electrophoretic separation of enantiomers has been
accomplished via an eight-step synthetic methodology. Development of new, highly
selective deprotection reaction conditions made possible these new derivatives in a
minimum number of synthetic steps. The overall yields for HMAS and HMS were 39%
and 25%, respectively. The final products, along with each intermediate, have been been
extensively characterized by analytical methods including HPLC-ELSD, indirect-UV
detection CE, MALDI-TOF MS, 1D and 2D NMR and X-ray diffraction crystallography
to show that, indeed, the single-isomer SISCDs were produced.
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CHAPTER III
ENANTIOMER SEPARATIONS
3.1 Use of HMAS and HMS as Chiral Resolving Agents
The structures of the twenty four, structurally diverse, weakly basic
pharmaceuticals selected to evaluate the utility of HMAS and HMS as chiral resolving
agents for use in CE enantiomer separations are shown in Figure 39. Separation
selectivity (α) was determined as a function of concentration of the chiral resolving agent
in two BGEs, including an aqueous low pH BGE and a methanolic low pH BGE, each
with variable HMAS or HMS concentrations. All twenty four weakly basic compounds
have been shown to have cationic effective mobilities under the selected conditions in
the absence of SISCD. The effective mobilities (µeff) and the normalized electroosmotic
mobilities (β) were calculated per Equations 1 and 8 (see Chapter I), respectively. Peak
resolution was calculated from peak half-height widths (wh) as Rs=[2(t2-
t1)]/[1.699(wh2+wh1)]. Migration time values used were taken at the point of infinite
dilution for peaks suffering electromigration dispersion (EMD). Effective mobilities and
separation selectivities were plotted as a function of the resolving agent concentration to
evaluate the best chiral resolving agent and concentration for the highest available
separation selectivity. Whenever possible, qualitative comparisons were made between
the separations achieved in aqueous and non-aqueous BGEs as well as to separations
achieved using other SISCDs bi-functionalized at the C-2 and C-3 hydroxyl groups.
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Figure 39. Names and structures of weakly basic analytes.
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Figure 39. Continued.
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3.2 Materials and Methods
All chiral analytes listed in Figure 39 were obtained from either Sigma (St. Louis,
MO), Aldrich Chemical Co. (Milwaukee, WI), Wiley Organics (Coshocton, OH) or
Research Diagnostics (Rockdale, MD). Dimethylsulfoxide (DMSO) and HPLC grade
methanol were purchased from EM Science (Gibbstown, NJ). Aqueous solutions were
prepared from deionized water obtained from an in-house Milli-Q unit (Millipore,
Milford, MA). All solutions were filtered prior to use with a 0.45 µm Nalgene nylon
membrane filter (VWR, South Plainfield, NJ). Naphthalenesulfonic acid (NSA),
phosphoric acid and lithium hydroxide were purchased from Aldrich Chemical Co.
HMAS and HMS were prepared as described in Chapter II.
Capillary electrophoretic measurements were made using either a P/ACE 2050 or
P/ACE 2100 CE instrument with its UV detector set to 214 nm. A 26.4 cm total length
(19.6 cm to detector), 27 µm i.d., naked fused-silica capillary was used for both the
aqueous and for the nonaqueous CE measurements. The aqueous BGE was buffered at
low pH with 25 mM H3PO4 (pKa1 2.1), titrated to pH 2.5 with LiOH. An acidic
methanolic buffer was prepared from 25 mM  H3PO4 and 12.5 mM NaOH for use in
nonaqueous measurements. The stock buffers were used to prepare the 0-30 mM SISCD
BGEs for CE enantiomer separations. The enantiomers were dissolved in the BGE and
co-injected for 1 s by 1 psi nitrogen with either the EOF marker or the anionic mobility
marker from a solution approximately 0.5 mM in both the analyte and the marker. Ohms
plots were measured from 0-30 mM SISCD at 2.5, 5, 10, 20 and 30 mM SISCD
concentrations in each BGE. Effective mobility measurements were carried out within
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the linear region of Ohms law. The effective mobilities of the enantiomers were
measured against either a dimethylsulfoxide (DMSO) neutral marker which possesses no
intrinsic charge and thus has zero effective mobility at the pH of the BGEs or NSA
which is a monovalent anion at the pH of the BGEs. The effective mobility of NSA in
the various SISCD containing BGEs was measured relative to DMSO using the three-
band PreMCE method [95].
3.3 Low pH Aqueous Separations Using HMAS as Chiral Selector
Effective mobilities for moderate molecular weight (200 < MW < 500), singly-
charged, weakly basic compounds usually lie in the +10 × 10-5 cm2V-1s-1 to +25 × 10-5
cm2V-1s-1 range. Consequently, use of low pH BGEs, where µeo values are around +10 ×
10-5 cm2V-1s-1 to +25 × 10-5 cm2V-1s-1 in naked fused silica capillaries, is conducive to
good resolution because more favorable β values are obtained than in high pH BGEs
where typical µeo values are higher than +50 × 10 cm2V-1s-1 [68]. Previous work  has
shown that, in the molecular weight range specified, complexation of weak bases with
SISCDs commonly leads to anionic effective mobilities as high as -25 mobility units (×
10-5 cm2V-1s-1) and occasionally as high as -33 mobility units. This means that it is
possible to adjust the concentration of SISCDs to bring about an effective mobility for
weakly basic enantiomers that is nearly equal in magnitude but opposite in direction to
the electroosmotic flow mobility and thus, take advantage of even the lowest separation
selectivity to achieve resolution [68]. For these reasons, evaluation of the potential of a
new SISCD to be used as a chiral resolving agent almost always begins with the
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separation of weakly basic enantiomers in low pH BGEs.
Table 1 lists the effective mobilities of the less mobile enantiomers, µ, the
separation selectivities, α, the peak resolution, Rs, the normalized EOF mobility values,
β, and the injector-to-detector potential drop, U, obtained in the low pH aqueous BGE
for the weakly basic enantiomers. An entry of N/A implies that a value could not be
calculated because of overlap with a non-comigrating system peak or overlap with the
neutral marker or anionic mobility marker. The applied potential was 20 kV at 2.5 mM
HMAS-containing BGE and decreased with increasing HMAS concentration to 10 kV at
30 mM HMAS-containing BGE. Over the 2.5 to 30 mM HMAS concentration range, the
µEOF values were 16 to 31 mobility units and were higher at greater HMAS
concentration. Higher µEOF values at greater HMAS concentrations likely indicate that
HMAS absorbs to the wall of the capillary since this would result in an increase in the
zeta potential at the fused silica capillary wall. No studies were conducted to quantify the
contribution to resolution resulting from chromatographic retention of the analytes.
There was at least some separation selectivity for the enantiomers of 19 of the 24
analytes in the aqueous BGE using HMAS as chiral resolving agent. Of these, 15 were
baseline resolved (i.e., Rs > 1.5) under the conditions used. For five analytes there was
no resolution including atropine, homatropine, chlorpheniramine, scopolamine and
diltiazem. Two of these, atropine and homatropine, were only weakly complexing at all
HMAS concentrations. Chlorpheniramine has a chiral center sterically crowded by two
aromatic rings, scopolamine is a doubly bridged heterocycle and diltiazem has no chiral
center rather, a chiral plane provided by the large, seven membered thiazepine ring. All 
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Table 1. Separations data in pH 2.5 aqueous HMAS BGEs (µ, in 10-5cm2/Vs units).
[HMAS] 0 mM*                                       2.5 mM
  U (kV)           14.8                                                    14.8
Analyte µ µ α β Rs
B04 21.5 -14.9 0.78 -1.6 3.5
B06 22.1 -18.9 0.69 -1.4 10.4
B09 16.5 5.5 1.00 4.4 0.0
B11 16.0 -8.7 0.74 -2.7 3.3
B13 21.4 -24.6 0.99 -0.66 <0.5
B14 16.0 4.3 1.22 5.4 1.2
B19 17.0 5.1 1.00 4.6 0.0
B21 15.7 -27.3 0.88 -0.59 3.9
B22 18.2 11.4 1.06 2.0 0.7
B23 15.4 -6.7 0.81 -3.4 3.1
B26 18.7 -7.1 1.00 -3.2 0.0
B28 20.1 -14.0 -0.44 -1.6 14.0
B30 17.3 -30.9 0.96 -0.55 2.8
B34 21.4 -15.6 0.76 -1.6 5.8
B38 19.8 -31.1 0.87 -0.5 5.0
B39 23.5 2.5 3.79 9.5 7.2
B42 16.5 -2.6 0.89 -0.6 5.9
B46 16.0 6.4 1.00 3.6 0.0
B47 16.1 -25.8 0.95 -0.64 2.0
B56 16.2 -20.9 1.00 -1.2 0.0
B57 10.4 5.3 1.00 0.0 45
B60 18.4 -12.2 0.58 -1.9 3.6
B61 20.8 -23.1 0.85 -1.3 5.6
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Table 1. Continued.
[HMAS]                     5 mM                                            10 mM
 U (kV)                   13.4                                               11.1
Analyte µ α β Rs µ α β Rs
B04 -19.9 0.83 -1.3 3.4 -19.8 0.87 -1.8 2.9
B06 -21.3 0.80 -1.2 6.5 -20.8 0.83 -1.6 4.9
B09 3.8 1.00 6.6 0.0 1.6 1.00 20 0.0
B11 -10.4 0.79 -2.4 3.3 -12.5 0.85 -2.4 4.0
B13 -24.7 0.99 -1.4 <0.5 -22.5 0.99 -1.6 <0.5
B14 2.1 1.52 11.8 0.6 N/A
B19 4.0 1.00 6.2 0.0 2.5 1.00 12 0.0
B21 -27.7 0.9 -1.2 6.9 -23.1 0.94 -1.4 4.9
B22 8.8 1.09 2.8 0.8 7.1 1.13 4.1 0.8
B23 -9.2 0.84 -2.8 4.4 -10.3 0.87 -2.8 4.4
B26 -9.3 0.98 -3.3 <0.5 -10.0 0.97 -2.9 0.6
B28 -16.3 -0.22 -1.5 12.1 -15.2 -0.04 -2.0 17
B30 -30.3 0.97 -0.68 3.2 -25.2 0.99 -1.2 2.7
B34 -17.4 0.83 -1.5 5.7 -17.3 0.86 -1.6 5.8
B38 -30.2 0.89 -0.8 9.6 -26.4 0.91 -1.2 12
B39 -3.4 -1.22 -7.3 10.4 -5.5 -0.38 -5.0 13
B42 -2.7 0.92 -0.76 9.2 -23.0 0.93 -1.2 13
B46 2.5 1.00 11.0 0.0 N/A
B47 -26.5 0.96 -0.78 3.9 -22.5 0.97 -1.3 4.1
B56 -20.1 1.00 -1.4 0.0 -17.0 1.00 -1.6 0.0
B57 -2.6 1.00 -9.2 0.0 -4.5 1.00 -6.2 0.0
B60 -16.3 0.72 -1.6 4.7 -15.5 0.77 -1.8 6.1
B61 -24.5 0.90 -1.2 10.4 -22.0 0.92 -1.3 15
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Table 1. Continued.
[HMAS]                           20 mM                                            30 mM
  U (kV)                      8.9                                                7.4
Analyt µ α β Rs µ α β Rs
B04 -19.6 0.88 -1.8 3.7 -16.3 0.89 -1.8 3.7
B06 -19.6 0.83 -1.5 5.7 -16.5 0.84 -1.7 6.4
B09 N/A N/A
B11 -12.6 0.85 -1.7 10.3 -11.6 0.86 -2.6 5.2
B13 -19.9 0.99 -1.6 0.6 -17.1 0.99 -1.7 0.5
B14 -1.1 0.66 -19 1.6 -1.9 0.87 -15 0.6
B19 1.1 1.00 20 0.0 0.70 1.00 41 0.0
B21 -20.9 0.94 -1.5 7.8 -18.5 0.95 -1.6 5.0
B22 6.0 1.18 3.6 2.3 4.5 1.21 6.9 1.7
B23 -10.9 0.92 -2.0 3.8 -11.1 0.93 -2.7 3.7
B26 -10.4 0.97 -2.0 1.4 -8.8 0.96 -3.3 1.3
B28 -13.8 0.03 -2.2 27 -11.6 0.06 -2.5 37
B30 -22.7 0.98 -1.3 3.8 -20.1 0.98 -1.5 2.7
B34 -16.7 0.87 -1.3 8.3 -13.9 0.87 -2.0 6.4
B38 -22.6 0.92 -1.3 11.4 -19.9 0.91 -1.5 11
B39 -7.0 -0.07 -2.5 22 -6.1 -0.02 -4.6 22
B42 -20.9 0.93 -1.4 5.3 -18.2 0.94 -1.6 8.7
B46 N/A -1.2 1.00 -24 0.0
B47 -20.2 0.98 -1.4 5.3 -11.8 0.98 -1.6 2.4
B56 -14.3 1.00 -2.2 0.0 -11.9 1.00 -2.3 0.0
B57 -6.0 1.00 -5.2 0.0 -6.5 1.00 -4.2 0.0
B60 -14.2 0.79 -2.6 5.2 -12.9 0.80 -2.2 4.7
B61 -19.6 0.93 -1.7 4.8 -17.4 0.93 -1.6 4.1
* From Ref. [39].
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are strongly complexing hence, lack of separation selectivity is likely due to the very
strong interaction with HMAS. The four remaining unresolved analytes showed some
separation selectivity but require more favorable β-values than provided by the
separation conditions used.
According to ref. [51], SISCD mediated separations of weakly basic compounds
generally fall into three categories: weakly binding, moderately strongly binding and
strongly binding. Categorization of the separations in this way provides some insight into
the separation selectivity patterns observed as well as allowing qualitative comparison of
the utility of the various available SISCDs for a given enantiomer separation. The
effective mobilities of weakly binding bases do not become anionic over the SISCD
concentration range used. The mobility (left panel) and separation selectivity (right
panel) curves for ketamine, B22, the only baseline resolved, weakly binding base, is
shown in the top panel of Figure 40. The effective mobility is initially cationic at
approximately 25 mobility units. As the HMAS concentration is increased, the effective
mobility approaches zero due to an increase in the mole fraction of the HMAS-analyte
complex and to ionic strength-related depression of the effective mobilities of both the
free and the complexed forms of the weak base. The separation selectivity curve
gradually increases without approaching a limiting value over the tested HMAS
concentration range.
The effective mobilities of moderately strongly binding bases are, like the weakly
binding bases, initially cationic but become anionic at some intermediate SISCD
concentration. The middle panel of Figure 40 shows the effective mobility (left panel)  
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Figure 40. Effective mobilities (left panel) and separation selectivities (right panel) of
weakly binding (top panel), moderately strongly binding (middle panel) and strongly
binding (bottom panel) weakly basic analytes. Zero concentration effective mobility
values as reported in Ref. [39].
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and the separation selectivity (right panel) for the two moderately strongly binding weak
bases, chlophedianol, B14, and phenylglycinonitrile, B39. In both cases, the effective
mobilities of the enantiomers are cationic at zero and low HMAS concentrations but at
an intermediate HMAS concentration become anionic. At HMAS concentrations where
the effective mobilities of both enantiomers are cationic, the separation selectivity is
positive and approaches an infinite value as the effective mobility of the faster migrating
enantiomer approaches zero. At higher HMAS concentrations, the separation selectivity
value is negative but becomes positive again and approaches unity as the HMAS
concentration is increased and the effective mobilities of both enantiomers remain
anionic.
Strongly binding bases include those whose effective mobilities have become
anionic already at very low SISCD concentrations. The bottom panel of Figure 40 shows
the mobility curves (left panel) and separation selectivity curves (right panel) for three
representative strongly binding weak bases, norephedrine, B34, terbutaline, B47, and
ephedrine, B60. Their effective mobilities are all anionic at HMAS concentrations as low
as 2.5 mM and remain anionic over the entire HMAS concentration range used. Their
effective mobilities approach zero at higher HMAS concentrations due to the effects of
higher ionic strength. The separation selectivities for all three analytes are positive, and
approach a limiting value of α < 1 with increasing HMAS concentrations. The α > 1
portions of the separation selectivity curves were not observed since they occur at
HMAS concentrations lower than 2.5 mM.
 Representative electropherograms obtained for the pH 2.5 separations of some of 
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Figure 41. Typical electropherograms of weak base analytes in pH 2.5 BGE with HMAS.
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Figure 41. Continued.
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the weak base enantiomers are shown in Figure 41. Each electropherogram includes the
analyte identifier (see Figure 30), the applied potential (in kV) and the HMAS
concentration used for the separation. Some include the zero mobility marker, denoted
DMSO, or the anionic mobility marker, denoted NSA. Baseline resolution was achieved
in all cases in short run times with the shortest run time at two minutes for
phenyglycinonitrile, B39, and the longest for the strongly binding phenylethanolamine,
B06, at twelve minutes. Average run times were three to six minutes.
3.3.1 Effects of Weak Base Structure on Separation Selectivity in Aqueous CE
Separations Using HMAS
An enantiomers binding strength is highly dependent on its structure and the
structure of the chiral resolving agent. Small structural changes in the analytes can lead
to dramatic changes in the separations. As an example, Figure 42 shows the effective
mobility (top panel) and the separation selectivity (bottom panel) curves for several
structurally related weak bases including B47, B30, B21, B26 and B60. Each is a
strongly binding weak base with effective mobilities varying from -9 mobility units for
B26 to -31 mobility units for B30 at 5mM HMAS. In order of increasing binding
strength, they are B30 > B47 >B21 > B60 > B26. It appears that the binding strength is
most dependent on the size and type of the substituents about the aromatic ring. The
most strongly binding enantiomers are the ortho- and meta- catecholamines due to strong
intermolecular interactions with HMAS. The least strongly binding are metanephrine,
B26, with one methylated phenol group and ephedrine, B60, with no phenol groups. 
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Figure 42. Effects of analyte structure on effective mobilities and separation selectivities
for weak bases B21, B26, B30, B47 and B60 obtained in pH 2.5 BGE using HMAS.
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Interestingly, the two weak bases with the least bulky aromatic substituents are also the
two with separation selectivities furthest from unity. Isoproterenol, B21, with its ortho-
phenol groups and ephedrine, B60, exhibit better separation selectivities than bulkier
terbutaline, B47, and metaproterenol, B30, each with phenolic group in meta- position
and metanephrine, B26, which possesses a methylated phenol group. These observations,
while valid, provide little insight into the enantiorecognition mechanism without
reinforcement from1-D ROESY NMR experiments [34,35,37].
3.4 Acidic Methanolic Separations Using HMAS as Chiral Selector
Non-aqueous CE (NACE) allows for separation of analytes with low water
solubility. Some NACE solvents have low viscosity and low conductivity, which permits
the use of higher potentials and lead to faster separations. Commonly used NACE
solvents include DMSO, N-methylformamide (NMF), N,N-dimethylformamide (DMF)
and  propylene carbonate (PC) as well as methanol (MeOH) and acetonitrile (ACN).
Some, such as DMSO, NMF, DMF, and PC have high UV cut-off values relative to the
others. The solubility of most SISCDs, including HMAS, is greater in methanol than
ACN, therefore methanol is the solvent of choice for SISCD enantiomer separations in
NACE BGEs. 
Study of the use of HMAS as a chiral resolving agent in an acidic methanol BGE
was carried out using the same set of 24 weakly basic enantiomers as used in the acidic
aqueous BGE (see Figure 39). Table 2 lists the effective mobilities of the less mobile
enantiomer (µ), the separation selectivity (α), the corresponding normalized 
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Table 2. Separations data in acidic methanol HMAS BGEs (µ, in 10-5cm2/Vs units).
[HMAS] 0 mM*                                     2.5 mM
  U (kV)  19.3                                                   19.3
Analyte µ µ α β Rs
B04 23.0 14.3 0.72 -10 1.0
B06 23.0 -17.0 0.76 -7.2 1.6
B09 21.2 -5.1 1.00 -2.8 0.0
B11 26.2 3.3 1.96 3.7 9.4
B13 24.5 -3.5 0.87 -4.2 1.9
B14 16.5 -3.0 1.00 -4.1 0.0
B19 14.0 -6.0 1.00 -2.4 0.0
B21 22.1 0.61 2.07 20.7 2.3
B22 25.6 9.7 1.03 0.6 1.5
B23 7.6 -8.5 0.98 -1.5 1.0
B26 19.3 -3.7 0.90 -3.4 1.3
B28 27.8 3.0 1.00 4.7 0.0
B30 18.3 -0.58 -0.47 -22 3.5
B34 23.4 1.9 1.00 7.8 0.0
B38 19.3 -6.3 0.91 -2.0 2.4
B39 26.5 0.58 1.37 25 0.7
B42 20.1 -4.6 0.95 -2.7 1.4
B46 16.1 -6.4 1.00 -2.3 0.0
B47 17.8 1.9 1.14 6.7 0.7
B56 14.4 -5.5 1.00 -2.7 0.0
B57 15.8 -1.9 1.00 -5.0 0.0
B60 26.3 1.1 1.30 14 0.8
B61 25.4 -2.1 0.92 -5.8 0.8
87
Table 2. Continued.
[HMAS]                    5 mM                                            10 mM
  U (kV)                   19.3                                              19.3
Analyte µ α β Rs µ α β Rs
B04 -17.7 0.78 -8.0 1.2 -2.8 0.89 -2.7 2.7
B06 -25.2 0.89 0.86 -4.5 -2.7 0.91 -2.8 1.3
B09 -5.5 1.00 -2.1 0.0 -4.3 0.99 -1.5 0.6
B11 2.2 2.63 7.34 5.4 1.7 2.68 4.5 7.9
B13 -3.3 0.89 -4.1 7.3 -3.0 0.90 -2.2 4.1
B14 -3.3 1.00 -2.4 0.0 -2.5 0.96 -2.7 1.1
B19 -5.7 1.00 -2.3 0.0 -5.3 1.00 -1.6 0.0
B21 N/A 0.30 -0.52 -22 3.9
B22 8.3 1.08 1.4 <0.5 7.8 1.11 0.87 0.9
B23 -7.5 0.98 -1.6 1.1 -5.9 0.98 -1.4 1.13
B26 -4.4 0.93 -2.5 1.9 -3.7 0.94 -2.0 2.5
B28 1.9 1.00 6.6 0.0 1.5 1.00 5.1 0.0
B30 -1.6 0.60 -6.5 3.6 -1.1 0.82 -6.8 1.9
B34 1.2 1.00 8.5 0.0 0.81 1.00 10.3 0.0
B38 -6.3 0.95 -1.7 2.3 -4.8 0.97 -1.8 1.2
B39 0.15 2.67 71 1.4 0.16 3.0 46 1.9
B42 -5.3 0.98 -2.0 0.6 -3.4 0.97 -1.8 1.2
B46 -6.3 1.00 -1.9 0.0 -5.1 1.00 -1.5 0.0
B47 -0.67 1.36 15 0.7 0.50 1.48 17 1.2
B56 -5.5 1.00 -1.9 0.0 -4.4 1.00 -1.7 0.0
B57 -5.2 1.00 -2.1 0.0 -4.0 1.00 -2.0 0.0
B60 -0.66 0.61 -15 0.9 -0.44 0.30 -18 2.3
B61 -3.3 0.93 1.03 1.0 -2.7 0.96 -3.1 1.0
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Table 2. Continued.
[HMAS]                   20 mM                                            30 mM
  U (kV)                    19.3                                              19.3
Analyte µ α β Rs µ α β Rs
B04 -2.0 0.87 -2.4 3.2 -1.6 0.84 -2.3 4.3
B06 -2.0 0.91 -2.5 2.2 -1.9 0.89 -2.0 3.9
B09 -3.0 1.00 -1.6 <0.5 -1.9 1.00 -1.8 0.0
B11 1.2 2.65 3.9 17 0.79 2.63 4.4 11
B13 -2.0 0.89 -2.4 1.9 -1.2 0.89 -2.8 2.0
B14 -1.8 0.97 -2.6 0.7 -1.4 0.97 -2.4 1.1
B19 -3.3 0.99 -1.3 1.2 -2.4 0.99 -1.4 0.9
B21 N/A -0.13 -0.75 -27 2.7
B22 6.8 1.13 0.70 3.0 -0.60 1.16 0.55 4.2
B23 N/A N/A
B26 -2.2 0.91 -2.1 4.9 -1.6 0.88 -2.1 6.4
B28 2.0 1.00 2.4 0.0 2.3 1.04 1.3 0.6
B30 0.36 0.77 -14 1.2 -0.29 0.48 -9.9 1.9
B34 0.52 1.00 10 0.0 -0.50 1.00 7.9 0.0
B38 -3.0 0.92 -1.5 4.6 -0.20 0.65 -14 1.7
B39 0.36 2.17 12 4.6 0.53 1.78 6.9 5.4
B42 -2.0 0.96 -2.3 1.4 -1.5 0.96 -2.7 0.7
B46 -3.4 1.00 -1.3 0.0 -2.5 1.00 -1.4 0.0
B47 0.68 1.19 6.9 2.0 0.77 1.12 4.5 1.6
B56 -2.8 1.00 -1.5 0.0 -2.4 1.00 -1.5 0.0
B57 -2.8 1.00 -1.6 0.0 -2.0 1.00 -1.7 0.0
B60 N/A 0.17 2.15 20 4.0
B61 -2.1 0.95 -2.1 1.9 -1.7 0.94 -2.1 2.8
* From Ref. [47].
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electroosmotic flow mobility (β), the peak resolution and the injector-to-detector
potential drop (U) values for the NACE separations. An entry of N/A implies that a value
could not be calculated because of overlap with a non-comigrating system peak or
overlap with the neutral marker or anionic mobility marker.
 All separations were carried out within the linear region of Ohms law with
applied potentials at 26 kV in all of the HMAS- containing BGEs. Over the 2.5 to 30
mM HMAS concentration range, the µEOF were as low as 9 mobility units in the 2.5 mM
HMAS- containing BGEs and as high as 41 mobility units in the 30 mM HMAS-
containing BGEs. Again, the higher µEOF values at greater HMAS concentration likely
indicate that HMAS adheres to the fused silica capillary wall resulting in a greater zeta
potential and higher µEOF values. No studies were conducted to quantify the contribution
to resolution resulting from chromatographic retention of the analytes.
The enantiomers of 18 of the 24 analytes showed at least some separation
selectivity in the methanolic BGE using HMAS as chiral resolving agent. Of these, 15
were baseline resolved (i.e., Rs > 1.5) under the conditions used. The six analytes for
which no resolution was achieved included the same five analytes that showed no
separation selectivity in aqueous BGEs plus norephedrine, B34. Norephedrine is only
weakly binding in the methanolic BGEs, unlike in the aqueous BGEs where it is
strongly binding.
Mobility (left panel) and separation selectivity (right panel) curves for some of
the weak base enantiomers are shown in the top panel of Figure 43. As in the aqueous
BGEs, migration behaviors of the weak bases studied fell into one of three mobility 
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Figure 43. Effective mobilities (left panel) and separation selectivities (right panel) of
weakly binding (top panel), moderately strongly binding (middle panel) and strongly
binding (bottom panel) weakly basic analytes. Zero concentration effective mobility
values as reported in Ref. [47].
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patterns. The weak bases whose effective mobilities remained cationic throughout the
HMAS concentration range are weakly binding (top panel) and have their effective
mobilities depressed toward zero by the increasing complexation and the increasing ionic
strength. There is no discontinuity in the separation selectivity pattern similar to the
aqueous CE separations weak base enantiomers.
 Isoproterenol, B21, is strongly binding in the aqueous BGEs (see Figure 42) but
is the only moderately strongly binding weak base in the methanolic BGEs. Moderately
strongly binding bases (middle panel) are cationic until, at some intermediate HMAS
concentration, their effective mobility becomes anionic and then is depressed back by the
ionic strength of the BGE to a lower, though anionic value as the HMAS concentration is
further increased.
The third mobility pattern (bottom panel) is similar to the pattern for strongly
binding bases observed in the aqueous measurements. The effective mobility of the
enantiomers becomes anionic at a low HMAS concentration, then rapidly decreases at
the higher HMAS concentrations due to increasing ionic strength. A discontinuity is
observed in the separation selectivity patterns of both the moderately and strongly
binding weak bases. The difference between the two is that the discontinuity occurs
lower in the HMAS concentration range for the strongly binding weak bases and at some
intermediate HMAS concentration for the moderately strongly binding weak bases. 
Good peak resolution can be seen for several of the enantiomers in Figure 44.
Weaker binding strengths in the methanolic BGEs combined with higher electric field
strengths allowed for significantly faster run times, with most analytes passing the UV-
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Figure 44. Typical electropherograms of weak base analytes in acidic methanol BGE
with HMAS.
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detector in under five minutes. One notable separation is that of the stereoisomers of
labetolol, B24, which possess two chiral centers. The enantiomers of B24 were only
poorly resolved in the aqueous BGEs but are baseline resolved in the methanolic BGE
in under seven minutes.
3.4.1 Ionic Strength Effects in NACE Separations
Maynard et al. [51] predicted that in high ionic strength BGEs, like HMAS-
containing BGEs, the effective mobility of weakly binding bases will show a cationic
effective mobility minimum and that the separation selectivity will approach a maximum
value after which, higher sulfated CD concentrations result in lower α values. Further,
the authors predicted that strongly binding analytes will have an initially cationic
effective mobility but, as the sulfated CD concentration is increased, the effective
mobility will show an anionic maximum, approach the zero mobility line and become
cationic again. The calculated separation selectivity plot for strongly binding analytes is
shown in Figure 45, reprinted with permission from Ref. [51]. The α value is
discontinuous at both zero mobility line crossovers, one at low sulfated CD
concentration and one at higher SISCD concentration. The authors showed that the
trends for a weakly binding analyte, 4-chloroamphetamine, followed closely those
predicted by the model using HMDS as chiral resolving agent. However, no strongly
binding analyte that crosses the zero mobility line twice has yet been found
experimentally.
 Figure 46 shows the effective mobility (top panel) and separation selectivity 
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Figure 45. Predicted separation selectivity plot for strongly binding weak bases.
Reprinted with permission from Ref. [51].
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Figure 46. Effective mobility (top) and separation selectivity (bottom) curves for B60
measured in acidic methanol HMAS BGEs.
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(bottom panel) of the strongly binding weak base, ephedrine, B60. The effective mobility
of B60 is initially cationic, shows a local anionic maximum, then decreases and becomes
cationic as the HMAS concentration is increased. The separation selectivity pattern
shows that α is initially positive, becomes negative and approaches a local maximum.
Finally, once the mobility is again cationic, the separation selectivity decreases to an α >
1 value as predicted in Ref. [51]. The two weakly binding weak bases B39 and B47
exhibited a cationic effective mobility minimum (see Table 2). Their separation
selectivities approach a maximum near 10 mM HMAS and are lower at both 2.5 and 30
mM HMAS.
 3.4.2 Comparison of Enantiomer Separations in Aqueous and Nonaqueous HMAS
Containing BGEs
With the exception of B09, B14, B19 and B46, the binding strengths of all
analytes were weaker in the acidic methanol BGEs compared to the pH 2.5 aqueous
BGEs. Of these four analytes, only B14 showed separation selectivity in both the
aqueous and methanolic BGEs. The other three showed no separation selectivity using
either aqueous or methanolic BGEs.
 Weaker analyte binding strengths in methanolic BGEs compared to aqueous
BGEs are typical. Figure 47 shows the effective mobility and separation selectivity
curves for B11, B13 and B14 using HMAS as chiral resolving agent in acidic aqueous
and methanolic BGEs. Analytes B11 and B13 are strongly binding in aqueous BGEs
but, are less anionic in the methanolic BGEs where B11 is only weakly binding. 
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Figure 47. Effective mobility (top) and separation selectivity (bottom) of weak bases in
low pH aqueous (left) and methanolic (right) HMAS BGEs.
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Conversely, the effective mobilities for B14 show that it is moderately strongly binding
in aqueous but strongly binding in methanolic BGEs. The α values are improved for
both B11 and B13 in the methanolic BGEs vs. the aqueous BGEs. Better α values in
the methanolic BGEs allowed for baseline resolution of B13 even though the β values
were more favorable in the aqueous BGEs. Baseline resolution was achieved for B11 in
both BGEs despite poor α values in the aqueous BGEs. Resolution could not be
obtained for B14 in the methanolic BGEs but good α values in the aqueous BGEs
allowed baseline resolution in spite of poor β values. 
The CHARM  model [68] predicts that the effective mobility of an enantiomer is
dependent on the infinite dilution mobilities of the free and complexed forms of the
enantiomer, the enantiomer-HMAS complexation constant and the HMAS concentration.
Thus, the greater cationic character of weak bases in methanolic BGEs is most likely a
combination of smaller enantiomer-HMAS complexation constants and less anionic
effective mobilities of the complexed form of the enantiomer due to, perhaps, ion pairing
between HMAS and sodium. 
3.5 Low pH Aqueous Separations Using HMS as Chiral Selector
The same set of 24 analytes were used to evaluate the utility of HMS as a chiral
resolving agent for CE as in the previous experiments that included HMAS as chiral
selector. All but 4 of the enantiomers showed at least some separation selectivity in the
pH 2.5 aqueous HMS-containing BGEs. Norephedrine, B34, scopolamine, B46,
chlorpheniramine, B56, and diltiazem, B57 remained unresolved despite favorable β 
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Table 3. Separations data in pH 2.5 aqueous HMS BGEs ( (µ, in 10-5cm2/Vs units).
  [HMS] 0 mM*                                                2.5 mM
  U (kV)       14.8                                                   14.8
Analyte µ µ α β Rs
B04 21.5 9.6 1.08 1.34 0.8
B06 22.1 10.3 1.05 1.21 <0.5
B09 16.5 -2.2 0.52 -5.8 2.3
B11 16.0 -4.8 0.81 -2.5 2.6
B13 21.4 -4.1 0.79 -3.0 1.6
B14 16.0 -10.5 0.70 -1.2 23
B19 17.0 2.3 1.55 4.9 3.0
B21 15.7 -1.2 -2.81 -9.5 5.9
B22 18.2 -1.1 0.17 -10 3.4
B23 15.4 -10.3 0.59 -1.1 180
B26 18.7 7.2 1.07 1.3 0.8
B28 20.1 10.2 1.04 0.99 0.5
B30 17.3 -21.9 0.68 -0.39 6.3
B34 21.4 6.7 1.00 1.5 0.0
B38 19.8 -19.5 0.75 -0.44 10
B39 23.5 14.6 1.00 0.63 0.0
B42 16.5 -14.9 0.85 -0.61 6.4
B46 16.0 4.1 1.00 2.5 0.0
B47 16.1 -23.6 0.81 -0.47 6.0
B56 16.2 -22.4 1.00 -0.40 0.0
B57 10.4 N/A
B60 18.4 7.5 1.07 1.2 1.1
B61 20.8 3.2 1.5 3.8 1.5
101
Table 3. Continued
  [HMS]                    5 mM                                            10 mM
  U (kV)                   13.4                                               11.1
Analyte µ α β Rs µ α β Rs
B04 5.9 1.13 1.2 1.8 3.7 1.26 1.0 4.0
B06 6.3 1.10 1.1 1.4 4.3 1.15 0.84 2.0
B09 -11.3 0.87 -0.06 6 -12.2 0.90 -0.17 5.0
B11 -10.3 0.92 -0.05 3.5 -12.6 0.95 -0.37 4.5
B13 -7.5 0.88 -0.04 2.9 -10.3 0.92 -0.39 5.0
B14 -17.3 0.81 -3.9 7.6 -19.9 0.89 -0.12 8.5
B19 -1.6 0.20 -3.9 7.6 -6.0 0.70 -0.30 16
B21 -3.9 0.26 -1.7 12.5 -8.2 0.64 -0.49 20
B22 -7.3 0.81 -0.10 3.4 -11.5 0.92 -0.09 3.2
B23 -13.5 0.67 -0.11 19 -19.6 0.78 -0.03 11
B26 4.8 1.12 1.4 1.9 2.6 1.22 0.83 3.3
B28 7.7 1.05 0.83 1.4 5.0 1.08 0.54 2.1
B30 -25.3 0.79 -0.06 7.1 -23.3 0.83 -0.14 9.0
B34 4.9 1.00 1.3 0.0 2.2 1.00 0.96 0.0
B38 -21.3 0.83 -0.03 6.2 -21.4 0.88 -0.17 0.0
B39 11.0 1.03 0.59 0.9 9.1 1.03 0.33 1.0
B42 -18.1 0.91 -0.06 3.2 -18.7 0.94 -0.17 6.0
B46 -1.3 1.00 -5.0 0.0 -5.8 1.00 -0.17 0.0
B47 -24.7 0.83 -0.04 5.2 -24.3 0.88 -0.10 5.3
B56 -22.8 1.00 -0.12 0.0 -18.6 1.00 -0.08 0.0
B57 -9.2 1.00 -0.19 0.0 -12.9 1.00 -0.08 0.0
B60 4.1 1.14 1.6 2.2 1.2 1.60 5.5 3.6
B61 0.8 1.65 8.8 2.0 -2.7 0.63 -3.5 4.2
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Table 3. Continued.
 [HMS]                  20 mM                                            30 mM
  U (kV)                     8.9                                                 7.4
Analyte µ α β Rs µ α β Rs
B04 2.3 1.32 3.4 2.8 1.2 1.33 2.7 2.5
B06 2.0 1.2 1.3 2.0 1.8 1.22 3.1 2.4
B09 -11.7 0.94 -0.32 4.5 -10.8 0.92 -0.14 4.2
B11 -13.1 0.97 -0.23 2.4 -11.6 0.98 -0.11 2.0
B13 -9.8 0.92 -0.14 4.4 -8.1 0.91 -0.14 6.8
B14 -17.1 0.91 -0.16 8.7 -14.6 0.92 -0.07 7.5
B19 -5.8 0.72 -0.22 18 -5.6 0.71 -0.17 14
B21 -7.9 0.67 -0.31 17 -6.5 0.64 -0.11 25
B22 -11.8 0.93 -0.08 5.3 -10.4 0.94 -0.05 4.8
B23 -17.3 0.82 -0.04 12 -14.9 0.84 -0.05 12
B26 1.3 1.48 1.36 5.1 1.0 1.54 2.4 5.4
B28 3.2 1.23 0.91 1.9 1.5 1.43 1.9 4.5
B30 -20.2 0.86 -0.05 9.7 -16.8 0.89 -0.06 8.2
B34 N/A N/A
B38 -18.2 0.88 -0.12 11 -15.4 0.87 -0.03 12
B39 8.2 1.03 0.50 1.0 7.6 1.02 0.33 0.7
B42 -16.0 0.94 -0.13 6.1 -13.1 0.95 -0.03 5.0
B46 -6.1 1.00 -0.32 0.0 -5.4 1.00 -0.02 0.0
B47 -20.7 0.90 -0.09 10 -17.5 0.91 -0.06 9.3
B56 -9.8 1.00 -0.10 0.0 -8.2 1.00 -0.13 0.0
B57 -12.7 1.00 -0.15 0.0 -11.3 1.00 -0.09 0.0
B60 -1.7 0.43 -2.7 2.9 -2.8 0.57 -1.9 5.8
B61 -3.5 0.79 -0.26 10 -2.8 0.74 -0.18 29
* From Ref. [39].
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values. Of the twenty that showed separation selectivity, phenylglycinonitrile, B39, was
the only analyte not baseline resolved under the separation conditions used.
Table 3 lists the effective mobilities of the less mobile enantiomers, µ, the
separation selectivities, α, the peak resolution, Rs, the normalized EOF mobility values, 
β, and the injector-to-detector potential drop, U values obtained in the low pH aqueous
BGEs for the weakly basic enantiomers. An entry of N/A implies that a value could not
be calculated because of overlap with a non-comigrating system peak or overlap with the
neutral marker or anionic mobility marker.  
The limiting applied potential values determined by the Ohms Law plots were
identical to those found for low pH aqueous HMAS-containing BGEs. The applied
potential was 20 kV for the 2.5 mM HMS-containing BGE and decreased with
increasing HMS concentration to 10 kV at 30 mM HMAS-containing BGE. Over the 2.5
to 30 mM HMS concentration range, the µEOF values were between 1 and 12 mobility
units but were lower at greater HMS concentrations. Lower µEOF values at greater HMS
concentrations are in accordance with expectations since higher viscosities and higher
ionic strengths result from higher HMS concentration. Also, the lower µEOF values at
higher HMS concentration indicate that HMS may adhere to the fused silica capillary
wall to a lesser extent than HMAS. No studies were conducted to quantify the
contribution to resolution from chromatographic retention of the analytes.
All three effective mobility and separation selectivity classes were also observed
when HMS was used as the chiral resolving agent. The effective mobility and separation
selectivity trends for a group of weak bases are shown in Figure 48. Weakly binding 
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Figure 48. Effective mobilities (left panel) and separation selectivities (right panel) of
weakly binding (top panel), moderately strongly binding (middle panel) and strongly
binding (bottom panel) weakly basic analytes. Zero concentration effective mobility
values as reported in Ref. [39].
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bases (top panel) show the same trends as observed for the weak base separations in
HMAS-containing BGEs. Their effective mobilities remain positive over the entire
HMS concentration range. The separation selectivity values increase monotonically with
no discontinuity, in some cases to a limiting value.
The effective mobility and separation selectivity trends for the moderately
strongly binding weak bases (middle panel) shown in Figure 49 indicate that better
separation conditions occur at intermediate HMS concentrations where the effective
mobilities of the enantiomers cross the zero mobility line. Though α is highest in this
region of the mobility curve, faster, more robust enantiomer separations methods use
lower HMS concentrations at the expense of separation selectivity. Higher
concentrations see the α value pass a discontinuity in the curve and then increase to a
limiting value of α < 1 where the effective mobility is anionic and run times are longer.
Strongly binding bases have effective mobilities that are anionic at the lowest HMS
concentration tested. The discontinuity in α observed for moderately strongly binding
bases occurs at HMS concentrations lower than included in this study.
Representative electropherograms for some of the weak base separations using
HMS as chiral resolving agent are included in Figure 49. Favorable β values and good
separation selectivities meant that most analytes could be separated at relatively low
HMS concentrations, with short analysis times. Two separations worth mentioning
include those of atropine, B09, and homatropine, B19, both of which were not resolved
in the HMAS-containing BGEs. Here, HMS is able to resolve these two analytes at 2.5
mM HMS in 4.5 and 27 minutes, respectively.
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Figure 49. Typical electropherograms of weak base analytes in pH 2.5 aqueous BGE
with HMS.
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Figure 49. Continued.
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3.5.1 Effects of Weak Base Structure on Aqueous Separations Using HMS
 The effective mobility (top panel) and separation selectivity (bottom panel) of
several structurally related weak bases used to evaluate the impact of analyte structure on
separations using HMS are shown in Figure 50. They are the same group that was used
for similar comparisons with HMAS as chiral resolving agent. The mobility curves show
that these same analytes are less strongly binding in the HMS BGEs. The effective
mobilities range between 5 to -25 mobility units at 5 mM HMS for B26 and B30,
respectively. The order of binding strength is B30 > B47 >B21 > B60 > B26. All binding
strengths are weaker compared to those observed in the HMAS BGEs.
All three effective mobility and separation selectivity classes are represented by
the curves included in Figure 50. Metanephrine, B26, is weakly binding, ephedrine, B60,
is moderately strongly binding while isoproterenol, B21, metaproterenol, B30, and
terbutaline, B47, are strongly binding. Their separation selectivity patterns follow the
same trends mentioned previously (see Section 3.5) but are better for the strongly
binding analytes in HMS BGEs. Better separation selectivities are possible for B26 in
low concentration HMAS BGEs but, more reproducible effective mobilities are
obtained in HMS BGEs where small fluctuations in the chiral resolving agent
concentration have less impact on the separation. The same is true for the separation of
B60 enantiomers. High separation selectivities are available in both HMAS and HMS
BGEs near the discontinuity in the α curve. However, since the discontinuity occurs at
higher HMS concentration than with HMAS, more robust methods are obtained with
HMS as chiral resolving agent.
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Figure 50. Effects of analyte structure on the effective mobilities and separation
selectivities for weak bases B21, B26, B30, B47 and B60 obtained in pH 2.5 BGE using
HMS.
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3.6 Effects of C2 and C3 β-CD Substituents on Weak Base Aqueous Separations 
The changes in the binding strength for a weak base due to differences in the
functionalization at the C2 and C3 positions are represented in the effective mobility (top
panel) and separation selectivity (bottom panel) curves shown in Figure 51  for
piperoxan, B38, using HMAS, HMS, HS, HDAS and HDMS as chiral resolving agents.
HDAS and HS values are from Ref. [55] and Ref. [56], respectively. The binding
strengths follow the order HDAS > HS > HMAS > HMS > HDMS. The effective
mobilities span the range -32 to -2 mobility units at low SISCD concentrations. The
separation selectivity values are at all concentrations best when using HDMS as chiral
resolving agent. 
Typically, the trend is for the di-acetyl substituted CDs to exhibit stronger
intermolecular interactions compared to the di-hydroxy substituted CDs which exhibit
stronger intermolecular interactions compared to the di-methyl substituted CDs. HMAS
and HMS are intermediate in the trend since they possess one acetyl or one hydroxy
group and one methyl group. Exceptions to the trend are numerous with one example
being terbutaline, B47. The effective mobility (top panel) and separation selectivity plots
for B47 are shown in Figure 52  using HMAS, HMS, HS, HDAS and HDMS as chiral
resolving agents.  HDAS and HS values are from Ref. [55] and Ref. [56], respectively.
Unlike the trend observed for B38, the binding strengths follow the order HMAS > HMS
> HS > HDAS > HDMS. The effective mobilities span the ranged -26 to +8 mobility
units at low SISCD concentrations. The separation selectivity values are good at low
HMAS, HMS, HS and HDAS concentrations, but best at higher HDMS concentrations. 
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Figure 51. Effective mobilities (top) and separation selectivities (bottom) of B38 in pH
2.5 aqueous BGEs with HDAS (star), HS (diamond), HMAS (triangle), HMS (square)
and HDMS (circle). Value in absence of SISCD is 19.4 mobility units but is omitted for
clarity.
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Figure 52. Effective mobilities (top) and separation selectivities (bottom) of B47 in pH
2.5 aqueous BGEs with HDAS (star), HS (diamond), HMAS (triangle), HMS (square)
and HDMS (square). Value in absence of SISCD is 16.5 mobility units but is omitted
for clarity.
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Because of favorable β values and good separation selectivity, peak resolution values for
the enantiomers of B47 were 6 and 2 at 2.5 mM HMAS and HMS, respectively.
 3.7 Acidic Methanolic Separations Using HMS as Chiral Selector 
The changes in effective mobilities and separation selectivities with changing
BGE solvent is a compelling reason to conduct separations trials in both aqueous and
methanolic BGEs despite the fact that sulfated cyclodextrins with non-acetylated and
non-methylated C2 and C3 hydroxy groups do not work very well in methanol. Since
HMS was available, studies were conducted to evaluate its utility in acidic methanolic
BGEs. HMS-containing acidic methanolic BGEs were used to study the effective
mobility and separation selectivity patterns obtained for the 24 weak base analytes. Only
12 of the analytes showed separation selectivity different from unity and four were
baseline resolved including, B06, B09, B13 and B34. The useful HMS concentration
range was only up to and including 10 mM HMS. Higher concentrations were found to
produce solutions with viscosities too high to be useful as CE BGEs. In this respect,
HMS proved ill-suited for resolving agent in acidic methanolic BGEs.
Table 4 lists the effective mobilities of the less mobile enantiomers, µ, the
separation selectivities, α, the peak resolution, Rs, the normalized EOF mobility values,
β, and the injector-to-detector potential drop, U values, obtained in the acidic methanolic
BGEs for the weakly basic enantiomers. An entry of N/A implies that a value could not
be calculated because of overlap with a non-comigrating system peak or overlap with the
neutral marker or anionic mobility marker.
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Table 4. Separations data in acidic methanol HMS BGEs (µ, in 10-5cm2/Vs units).
  [HMS] 0 mM*                                              2.5 mM
  U (kV)  19.3                                                   19.3
Analyte µ µ α β Rs
B04 23.0 1.1 1.00 106 0.0
B06 23.0 -12.8 0.81 -1.1 3.8
B09 21.2 -13.9 1.00 -10 0.0
B11 26.2 15.7 1.00 0.92 0.0
B13 24.5 -7.6 0.23 -1.8 2.1
B14 16.5 4.4 1.00 3.4 0.0
B19 14.0 -4.9 1.00 -3.0 0.0
B21 22.1 7.0 1.00 2.1 0.0
B22 25.6 12.8 1.00 1.1 0.0
B23 7.6 -5.4 1.00 -2.6 0.0
B26 19.3 1.2 1.00 10 0.0
B28 27.8 14.1 1.00 1.1 0.0
B30 18.3 7.3 1.00 2.2 0.0
B34 23.4 4.6 1.00 3.0 0.0
B38 19.3 N/A
B39 26.5 0.5 2.02 29 0.0
B42 20.1 7.2 1.00 2.2 0.0
B46 16.1 -0.5 1.00 -30 0.0
B47 17.8 8.5 1.00 8.8 0.0
B56 14.4 1.6 1.00 8.8 0.0
B57 15.8 -1.2 1.00 -13.5 0.0
B60 26.3 9.6 1.00 1.7 0.0
B61 25.4 -1.4 0.28 1.6 -9.6
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Table 4. Continued.
  [HMS]                  5 mM                                            10 mM
  U (kV)                   19.3                                              19.3
Analyte µ α β Rs µ α β Rs
B04 -2.4 1.00 -5.8 0.0 -3.3 1.00 -4.1 0.0
B06 -12.8 0.90 -1.1 7.7 -12.1 0.91 -1.2 3.0
B09 -2.7 1.00 -5.0 0.0 -4.0 0.81 -3.0 3.3
B11 13.5 1.00 1.0 0.0 12.7 1.00 1.2 0.0
B13 -7.7 0.39 -1.9 9.8 -7.8 0.38 -2.0 9.7
B14 3.6 1.00 3.8 0.0 3.4 1.00 4.4 0.0
B19 -4.9 1.00 -3.1 0.0 -4.2 0.94 -3.6 0.6
B21 6.5 1.00 2.3 0.0 5.3 1.00 2.7 0.0
B22 11.9 1.00 1.3 0.0 10.3 1.00 1.4 0.0
B23 -6.0 1.00 -2.4 0.0 -6.4 0.96 -2.1 0.8
B26 -3.9 0.76 -3.5 0.9 -2.6 0.76 -4.7 1.4
B28 10.4 1.00 1.4 0.0 8.5 1.05 1.5 <0.5
B30 5.3 1.00 2.8 0.0 4.3 1.00 2.9 0.0
B34 N/A -1.4 0.52 -9.0 1.7
B38 N/A N/A
B39 -0.3 -2.08 2.6 -60 -0.6 -0.63 -24 3.9
B42 4.7 1.00 3.3 0.0 3.6 1.06 3.8 <0.5
B46 -1.6 1.00 -9.5 0.0 -3.2 1.00 -4.3 0.0
B47 6.6 1.00 2.3 0.0 5.4 1.00 2.6 0.0
B56 1.1 1.00 14 0.0 0.9 1.00 15 00
B57 -14.2 1.00 2.2 0.0 -2.1 1.00 -6.5 0.0
B60 6.7 1.00 2.2 0.0 4.8 1.00 2.8 0.0
B61 -7.8 0.74 -1.9 1.8 -7.6 0.84 -1.6 1.3
* From Ref. [47].
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All separations were carried out within the linear region of Ohms law with
applied potentials at 26 kV in all of the HMS-containing BGEs. Over the 2.5 to 10 mM
HMS concentration range, the µEOF was as high as 16 mobility units in the 2.5 mM
HMAS-containing BGEs, but decreased with increasing HMS concentration to as low
as 12 mobility units in the 10 mM HMS-containing BGEs. Decreasing EOF with
increasing HMS concentration is as expected due to higher BGE viscosity.  
The change in effective mobility of the weak bases with changing HMS
concentration in acidic methanol BGEs showed weakly binding, moderately strongly
binding and strongly binding trends. In general, binding strengths were much weaker in
the methanolic HMS BGEs than in the aqueous HMS BGEs thus, β values were less
favorable for resolution. Exceptions were the same four analytes that showed baseline
resolution in the methanolic HMS BGEs. Trends in the α curves were similar to those
observed previously for the 12 analytes showing some separation selectivity.
 3.8 Summary
The first two unsymmetrically substituted single-isomer, sulfated β-CDs, the
sodium salts of HMAS and HMS have been used to study the effective mobility and
separation selectivity patterns of the enantiomers of 24 weak base pharmaceutical
compounds in acidic aqueous BGEs. The study also included successful use of HMAS
in acidic methanol BGEs, while HMS in the same BGEs proved far less useful. The
trends observed in all cases followed closely the predictions of the CHARM model. Use
of HMAS and HMS provided differences in effective mobility and separation
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selectivities that were often complimentary to those for the same analytes using other
sulfated β-CDs. Finally, HMAS and HMS proved to be broadly useful to achieve
enantiomer resolutions of a combined 21 of 24 weak base analytes between the two. 
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CHAPTER IV
CONCLUSIONS
HMAS and HMS are SISCDs that are unsymmetrically substituted at the C2 and
C3 positions of the glucopyranose subunits. The synthetic methodology used to produce
these new derivatives utilized highly regioselective, orthogonally deprotectable,
organosilicon chemistry to allow per-modification at the C2 positions only. This was
made possible by first protecting the C6 positions with TBS followed by protection of
the C2 positions with a TES group. The first step has long been used as a means to bi-
functionalized SISCDs where the C2 and C2 positions are modified in a one-pot
reaction with either methyl or acetyl groups. This technique has been applied to produce
nine different SISCDs from three kinds of cyclodextrins, α-, β- and γ- CDs. The other
three SISCDs are produced by hydrolysis of the acetyl group following sulfation of the
C6 positions. 
The TBS protecting group has long been a staple to those desiring new, useful
cyclodextrin derivatives. Until now, other organosilicon protecting groups have received
little attention because only the bulkiest offer the necessary regioselectivity. The problem
of furthering cyclodextrin chemistry has been, in part, the lack of similarly highly
regioselective deprotection methods that would distinguish between different, sterically
hindered organosilicon protecting groups such as TES, TIPS (triisopropylsilyl), TBS and
the diphenyl version, TBDPS. Development of novel reaction conditions utilizing
imidazolium chloride to remove a TES protecting group at the C3 positions without
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deprotection of the TBS protecting group at the C6 positions allowed for the first time
per-modification of the C2 positions without concurrent modification of the C3 or C6
positions. 
The TBS protection of C6, TES protection of C2, methylation of C2 (TES
migrates to C3), and removal of the TES group to expose the C3 hydroxy groups have
been scaled to 2 kg, 1 kg, 0.5 kg and 1 kg, respectively. Conversion rates for the TBS
protection step were lowest at 83% with all others in excess of 96%. Yields after
purification were lowest for the TBS protection and TES deprotection steps with 70%
and 76%, respectively. All others were in excess of 90% yields with the TES protection
step highest at 96% yield. Purification of each intermediate was accomplished using
suitable recrystallization solvents.
Subsequent synthetic transformations began with acetylation of the C2 hydroxy
groups, TBS deprotection and sulfation of the now exposed C6 hydroxy groups to
produce HMAS. Hydrolysis of the C3 acetyl groups provided HMS. The acetylation
reaction proceeded slowly with 96% conversion, the major impurity being a desilylation
product as verified by MALDI-TOF MS. The deprotection, sulfation and deacetylation
reactions were much faster and proceeded with 99% conversion for the deprotection step
and > 97% for the sulfation and deacetylation reactions. Yields after purification were   
> 90% for all but the deacetylation reaction which gave only 65% yield after a costly
recrystallization step. The TBS deprotection and sulfation products were purified by
more efficient recrystallization methods. The acetylation product was purified using a
counter-current DMF/hexanes extraction process.
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Each synthetic product was characterized as to purity using either HPLC-ELSD
for the non-ionic intermediates or indirect-UV CE detection for final ionic products,
HMAS and HMS. One and two-dimensional 1H and 13C NMR and MALDI-TOF MS
was used to structurally characterize each intermediate. Also, X-ray crystallography was
used to confirm the expected substitution pattern. 
HMAS and HMS were used to study the separation selectivity and effective
mobility trends for a set of 24 pharmaceutically active weak base enantiomers. The
BGEs were simple 25 mM phosphoric acid solution buffered to pH 2.5. The capillary
was uncoated, bare fused silica and applied potentials were kept at maximums dictated
by the linear region of Ohms Law plots. The effective mobility trends for the weak
bases agreed well with the predictions of the CHARM model as did the separation
selectivity curves. All three categories of binding strengths described in the literature
were observed. Most analytes fell into the strongly binding category in both aqueous and
methanolic BGEs, though the binding strengths were consistently weaker in the
methanolic BGEs.
Binding strengths were found to be highly dependent on the structures of the
analytes and chiral resolving agent. A group of structurally similar catecholamines
included in the test set showed that changes in substitution about the aromatic ring can
result in dramatic changes in the both the effective mobility and separation selectivity
trends. The effect was most prominent in the aqueous HMS-containing BGEs where
effective mobilities of the analytes spanned the +5 to -25 mobility unit range at 5 mM
HMS. The binding strengths were stronger in the aqueous HMAS BGEs and varied over
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only -9 to -31 mobility units. Similar findings resulted from the comparison of the
effective mobility and separation selectivity trends of piperoxan and terbutaline in acidic
aqueous BGEs using numerous different single-isomer, sulfated β-cyclodextrins. The
binding strength of the enantiomers of piperoxan was strongest for HDAS and HS and
decreased in the order HDAS > HS > HMAS > HMS > HDMS. The binding strengths of
the enantiomers of terbutaline were strongest for HMAS and decreased in the order
HMAS > HMS > HS > HDAS > HDMS. The variation in such trends is a driving force
for development of new single-isomer, sulfated CDs, since the new CD derivatives will
undoubtedly offer different binding strengths and thus different separation selectivities. 
In conclusion, the two new chiral resolving agents, HMAS and HMS proved
broadly useful and in many cases, complimentary to other sulfated cyclodextrins used for
CE separation of the enantiomers of weak bases. HMAS and HMS afforded fast
separations with good resolution of 21 of the 24 analytes studied using either aqueous or
methanolic BGEs, most in under 10 minutes. The three analytes for which no resolution
was observed using either HMAS or HMS included diltiazem, scopolamine and
chlorpheniramine. HMS gave poor separation selectivities for most of the analytes
included in this study when used in acidic methanol BGEs with the exceptions of
chlophedianol and phenylglycinonitrile. The separation selectivities for these two were
highest in the methanolic HMS BGEs.
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APPENDIX B
SYNTHESIS PROTOCOL FOR HMAS AND HMS
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Heptakis(2-O-triethylsilyl-6-O-t-butyldimethylsilyl)cyclomaltoheptaose (3).- To a
mechanically stirred, sealed reaction vessel containing a solution of dry (2) (1.0 kg) and
imidazole (284.5 g) in dry THF (2 L), then add drop-wise over a 4 hr period TESCl (600
g) in EtOAc (1 L). Add imidazole (5.1 g) to the THF/EtOAc mixture add drop-wise over
a 10 min period TESCl (10.9 g) in EtOAC (20 mL). Repeat this last step until the
relative area of the undersilylated side-product is lower than 0.5% as measured by RP-
HPLC-ELSD (gradient elution 50:50 MeOH:EtOAc to 0:100 MeOH:EtOAC in 15 min
at 2 mL/min). Filter the imidazolium chloride and wash with 2 x 250 mL EtOAc.
Remove the solvent under reduced pressure to obtain a white solid. Slurry the crude
product in refluxing acetone (5 L) for 1 hr. Allow to cool to room temperature and filter
to obtain a white solid. Repeat the refluxing slurrying step two more times or until the
isomeric purity is >99.5% as measured by RP-HPLC-ELSD. Dry the purified product in
100°C vacuum oven to a constant weight. Typical yield is 96%.
Heptakis(2-O-methyl-3-O-triethylsilyl-6-O-t-butyldimethylsilyl)cyclomalto
heptaose(4).- To a mechanically stirred, sealed reaction vessel containing dry NaH (33.8
g) in THF (0.2 L) add, over a 45 min period, a solution of (3) (0.5 kg) and CH3I (104
mL) in THF (1 L) and stir for 4 hr while monitoring completion of the reaction by RP-
HPLC-ELSD (30:70 MeOH: EtOAc at 2 mL/min). Add anhydrous ethanol (50 mL) to
quench. Allow the reaction mixture to stir for 30 min and add hexanes (85%, 1.2 L).
Extract with 2 x1.2 L water. Back extract the water layers with 2 x 200 mL hexanes.
Combine the hexanes layers and remove the solvent under reduced pressure. Slurry the
crude product in refluxing acetone (3 L) for 30 min. Allow the slurry to cool to room
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temperature and filter to obtain a white solid. Repeat the refluxing slurrying step 5-6
times or until the isomeric purity is >99.5 % as measured by RP-HPLC-ELSD. Dry the
product in an 80°C vacuum oven to a constant weight.
Heptakis(2-O-methyl-6-O-t-butyldimethyl)cyclomaltoheptaose (5).- To a sealed,
mechanically stirred reaction vessel containing dry imidazolium chloride (413.5 g) in a
35% v/v MeOH in THF, prepared by mixing 3.6 L anhydrous MeOH and 6.7 L
anhydrous THF, add (4) (1 kg) and stir in a 60°C water bath for 4 hrs. Monitor the
reaction by RP-HPLC-ELSD (gradient elution 50:50 MeOH: EtOAc to 0:100
MeOH:EtOAc in 10 min at 2 mL/min). Typical reaction times are 6 hrs. Remove the
solvent under reduced pressure to obtain a white solid. Redissolve the crude in EtOAc (1
L) and filter the imidazolium chloride. Wash the filter cake with 2 x 250 mL EtOAc.
Combine with washes with the filtrate and in a magnetically stirring beaker add MeOH
(3 L). Allow to stir for 3 hr to complete recrystallization. Filter the white solid and repeat
the recrystallization step until isomeric purity is >99.5% as measured by RP-HPLC-
ELSD. Typical yields are 91%. Dry the product in a 110°C vacuum oven to a constant
weight.
Heptakis(2-O-methyl-3-O-acetyl-6-O-t-butyldimethylsilyl)cyclomaltoheptaose
(6).- To a sealed, magnetically stirred reaction vessel containing pyridine (0.5 L), add (5)
and continue to stir until it dissolves. Add acetic anhydride (325 mL) and stir for 30 hrs
suspended in a 50°C bath. Monitor the reaction using RP-HPLC-ELSD (45:55
MeOH:EtOAc isocratic mobile phase at 2 mL/min) and NP-HPLC-ELSD (95:5
CHCl3:MeOH to 0:100 CHCl3:MeOH in 7 min with 2 mL/min flow rate). Typical
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reaction times are 48-52 hr. After the reaction period is complete, remove the solvent and
acetic anhydride under reduced pressure to obtain the crude product. Extract in a
counter-current process using 1% v/v water in DMF and hexanes (85%). The target will
accumulate in the hexanes layer. Remove the hexanes from the product under reduced
pressure to obtain the product with >99.5% isomeric purity. Typical yield is 90%. Dry
the material in an 80°C vacuum oven to a constant weight.
Heptakis(2-O-methyl-3-O-acetyl)cyclomaltoheptaose (7).- To a sealed,
magnetically stirred reaction vessel containing MeOH (1 L) add hydrofluoric acid (48%
in water, 54.5 mL) and suspend in a 50°C bath. Add (6) (0.5 kg) and sodium fluoride
(15.3 g). Not all NaF will dissolve. Monitor progress of the reaction using RP-HPLC-
ELSD (gradient mobile phase 5:95 THF:H2O to 25:75 THF:H2O in 12 min then to 0:100
THF:H2O in 10 min at 2mL/min). Typical reaction times are 52-59 hr. After the reaction
period, filter the excess NaF and remove the solvent under reduced pressure. Redissolve
the white solid in dichloromethane (1.2 L) and filter the remaining sodium fluoride.
Slurry the crude product in refluxing diethyl ether (1.5 L) for 1 hr. Filter the product and
repeat the refluxing slurrying 4-5 times or until all TBS fluoride is removed as indicated
by 1H-NMR.
Heptakis(2-methyl-3-O-acetyl-6-O-sulfo)cyclomaltoheptaose (8).- To a sealed,
magnetically stirred reaction vessel containing dimethylformamide (300 mL) and (7)
(200 g) add sulfur trioxide-pyridine complex (175.1 g) and stir for 30 min. Monitor the
reaction progress using indirect-UV CE (30 mM β-alanine titrated to pH=3.5 with para-
toluenesulfonic acid, polarity is (+) to (-) at 20 kV, capillary is 46 cm long, 39 cm to
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detector, detector at 214 nm). Typical reaction times are 1 hr. Slowly add a slurry of
sodium bicarbonate (194 g) in water (200 mL). Remove the solvent under reduced
pressure. Dissolve the crude product in MeOH (200 mL) and filter the Na2SO4 by-
product. Precipitate the product by pouring the filtrate into diethyl ether (700 mL) and
filter to obtain a white solid. Repeat the precipitation step 6-8 times or until DMF
removal is complete as indicated by 1H-NMR. Typical yield is 94%. Dry the product in
an 80°C vacuum oven to a constant weight.
Heptakis(2-O-methyl-6-O-sulfo)cyclomaltoheptaose (9).- To a 1 L round bottom
flask equipped with a magnetic stir bar containing (8) (100 g) in water (250 mL), add
sodium hydroxide in water (32.6 mL), drop-wise, over a 30 min period. Stir for 1 hr.
Monitor the reaction progress using indirect-UV CE (30 mM β-alanine titrated to pH=3.5
with para-toluenesulfonic acid, polarity is (+) to (-) at 20 kV, capillary is 46 cm long, 39
cm to detector, detector at 214 nm). Reduce the contents of the flask to approximately
100 mL in volume under reduced pressure. Precipitate the product by pouring the
contents of the flask in isopropanol (500 mL). Filter the precipitate quickly, before the
sodium acetate precipitates. Repeat the precipitation step 4 times or until CE indicates
that all sodium acetate has been removed. Typical yield is 65%, with isomeric purity
>98%.
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